[English] 日本語
Yorodumi Papers
- Database of articles cited by EMDB/PDB/SASBDB data -

+
Search query

Keywords
Structure methods
Author
Journal
IF

-
Structure paper

TitlePanDDA analysis group deposition
Journal, issue, pagesTo Be Published
Publish dateMay 15, 2017 (structure data deposition date)
AuthorsKrojer, T. / Talon, R. / Fairhead, M. / Diaz Saez, L. / Bradley, A.R. / Aimon, A. / Collins, P. / Brandao-Neto, J. / Douangamath, A. / Ruda, G.F. ...Krojer, T. / Talon, R. / Fairhead, M. / Diaz Saez, L. / Bradley, A.R. / Aimon, A. / Collins, P. / Brandao-Neto, J. / Douangamath, A. / Ruda, G.F. / Szommer, T. / Srikannathasan, V. / Elkins, J. / Spencer, J. / London, N. / Nelson, A. / Brennan, P.E. / Huber, K. / Bountra, C. / Arrowsmith, C.H. / Edwards, A. / von Delft, F.
External linksSearch PubMed
MethodsX-ray diffraction
Resolution1.05 - 3.28 Å
Structure data

PDB-5q1j:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMSOA000341b
Method: X-RAY DIFFRACTION / Resolution: 1.42 Å

PDB-5q1k:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000074a
Method: X-RAY DIFFRACTION / Resolution: 1.42 Å

PDB-5q1l:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000073a
Method: X-RAY DIFFRACTION / Resolution: 1.76 Å

PDB-5q1m:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000740a
Method: X-RAY DIFFRACTION / Resolution: 1.56 Å

PDB-5q1n:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000295a
Method: X-RAY DIFFRACTION / Resolution: 1.38 Å

PDB-5q1o:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000478a
Method: X-RAY DIFFRACTION / Resolution: 1.25 Å

PDB-5q1p:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000299a
Method: X-RAY DIFFRACTION / Resolution: 1.56 Å

PDB-5q1q:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000294a
Method: X-RAY DIFFRACTION / Resolution: 1.44 Å

PDB-5q1r:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000291a
Method: X-RAY DIFFRACTION / Resolution: 1.49 Å

PDB-5q1s:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with BDOOA011525c
Method: X-RAY DIFFRACTION / Resolution: 1.62 Å

PDB-5q1t:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000492a
Method: X-RAY DIFFRACTION / Resolution: 1.49 Å

PDB-5q1u:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000351a
Method: X-RAY DIFFRACTION / Resolution: 1.5 Å

PDB-5q1v:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000166a
Method: X-RAY DIFFRACTION / Resolution: 1.57 Å

PDB-5q1w:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000546a
Method: X-RAY DIFFRACTION / Resolution: 1.68 Å

PDB-5q1x:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000085a
Method: X-RAY DIFFRACTION / Resolution: 1.42 Å

PDB-5q1y:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000032a
Method: X-RAY DIFFRACTION / Resolution: 1.42 Å

PDB-5q1z:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000150a
Method: X-RAY DIFFRACTION / Resolution: 1.41 Å

PDB-5q20:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000524a
Method: X-RAY DIFFRACTION / Resolution: 1.76 Å

PDB-5q22:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000728a
Method: X-RAY DIFFRACTION / Resolution: 1.18 Å

PDB-5q23:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000543a
Method: X-RAY DIFFRACTION / Resolution: 1.32 Å

PDB-5q24:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000676a
Method: X-RAY DIFFRACTION / Resolution: 1.35 Å

PDB-5q25:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000532a
Method: X-RAY DIFFRACTION / Resolution: 1.43 Å

PDB-5q26:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000710a
Method: X-RAY DIFFRACTION / Resolution: 1.66 Å

PDB-5q27:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000421a
Method: X-RAY DIFFRACTION / Resolution: 1.83 Å

PDB-5q28:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000186a
Method: X-RAY DIFFRACTION / Resolution: 1.52 Å

PDB-5q29:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000058a
Method: X-RAY DIFFRACTION / Resolution: 1.46 Å

PDB-5q2a:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 1)
Method: X-RAY DIFFRACTION / Resolution: 1.5 Å

PDB-5q2b:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 3)
Method: X-RAY DIFFRACTION / Resolution: 1.33 Å

PDB-5q2c:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 4)
Method: X-RAY DIFFRACTION / Resolution: 1.53 Å

PDB-5q2d:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 5)
Method: X-RAY DIFFRACTION / Resolution: 1.4 Å

PDB-5q2e:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 6)
Method: X-RAY DIFFRACTION / Resolution: 1.5 Å

PDB-5q2f:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 7)
Method: X-RAY DIFFRACTION / Resolution: 1.47 Å

PDB-5q2g:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 8)
Method: X-RAY DIFFRACTION / Resolution: 1.49 Å

PDB-5q2h:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 9)
Method: X-RAY DIFFRACTION / Resolution: 1.72 Å

PDB-5q2i:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 10)
Method: X-RAY DIFFRACTION / Resolution: 2.33 Å

PDB-5q2j:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 11)
Method: X-RAY DIFFRACTION / Resolution: 1.3 Å

PDB-5q2k:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 12)
Method: X-RAY DIFFRACTION / Resolution: 1.65 Å

PDB-5q2l:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 13)
Method: X-RAY DIFFRACTION / Resolution: 1.42 Å

PDB-5q2m:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 14)
Method: X-RAY DIFFRACTION / Resolution: 1.28 Å

PDB-5q2n:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 15)
Method: X-RAY DIFFRACTION / Resolution: 1.38 Å

PDB-5q2o:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 16)
Method: X-RAY DIFFRACTION / Resolution: 1.75 Å

PDB-5q2p:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 17)
Method: X-RAY DIFFRACTION / Resolution: 1.55 Å

PDB-5q2q:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 18)
Method: X-RAY DIFFRACTION / Resolution: 1.44 Å

PDB-5q2r:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 19)
Method: X-RAY DIFFRACTION / Resolution: 1.37 Å

PDB-5q2s:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 20)
Method: X-RAY DIFFRACTION / Resolution: 1.52 Å

PDB-5q2t:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 21)
Method: X-RAY DIFFRACTION / Resolution: 1.52 Å

PDB-5q2u:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 22)
Method: X-RAY DIFFRACTION / Resolution: 1.37 Å

PDB-5q2v:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 23)
Method: X-RAY DIFFRACTION / Resolution: 1.58 Å

PDB-5q2w:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 24)
Method: X-RAY DIFFRACTION / Resolution: 1.53 Å

PDB-5q2x:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 25)
Method: X-RAY DIFFRACTION / Resolution: 1.5 Å

PDB-5q2y:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 26)
Method: X-RAY DIFFRACTION / Resolution: 1.61 Å

PDB-5q2z:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 27)
Method: X-RAY DIFFRACTION / Resolution: 1.55 Å

PDB-5q30:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 28)
Method: X-RAY DIFFRACTION / Resolution: 1.8 Å

PDB-5q31:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 29)
Method: X-RAY DIFFRACTION / Resolution: 1.55 Å

PDB-5q32:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 30)
Method: X-RAY DIFFRACTION / Resolution: 1.87 Å

PDB-5q33:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 31)
Method: X-RAY DIFFRACTION / Resolution: 1.37 Å

PDB-5q34:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 32)
Method: X-RAY DIFFRACTION / Resolution: 1.49 Å

PDB-5q35:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 33)
Method: X-RAY DIFFRACTION / Resolution: 1.47 Å

PDB-5q36:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 34)
Method: X-RAY DIFFRACTION / Resolution: 1.39 Å

PDB-5q37:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 35)
Method: X-RAY DIFFRACTION / Resolution: 1.5 Å

PDB-5q38:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 36)
Method: X-RAY DIFFRACTION / Resolution: 1.39 Å

PDB-5q39:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 37)
Method: X-RAY DIFFRACTION / Resolution: 1.7 Å

PDB-5q3a:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 38)
Method: X-RAY DIFFRACTION / Resolution: 1.48 Å

PDB-5q3b:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 39)
Method: X-RAY DIFFRACTION / Resolution: 2.52 Å

PDB-5q3c:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 40)
Method: X-RAY DIFFRACTION / Resolution: 1.41 Å

PDB-5q3d:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 41)
Method: X-RAY DIFFRACTION / Resolution: 1.71 Å

PDB-5q3e:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 42)
Method: X-RAY DIFFRACTION / Resolution: 1.49 Å

PDB-5q3f:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 43)
Method: X-RAY DIFFRACTION / Resolution: 1.39 Å

PDB-5q3g:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 44)
Method: X-RAY DIFFRACTION / Resolution: 1.29 Å

PDB-5q3h:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 45)
Method: X-RAY DIFFRACTION / Resolution: 1.56 Å

PDB-5q3i:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 46)
Method: X-RAY DIFFRACTION / Resolution: 1.53 Å

PDB-5q3j:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 47)
Method: X-RAY DIFFRACTION / Resolution: 1.44 Å

PDB-5q3k:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 48)
Method: X-RAY DIFFRACTION / Resolution: 1.39 Å

PDB-5q3l:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 49)
Method: X-RAY DIFFRACTION / Resolution: 1.61 Å

PDB-5q3m:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 50)
Method: X-RAY DIFFRACTION / Resolution: 1.34 Å

PDB-5q3n:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 51)
Method: X-RAY DIFFRACTION / Resolution: 1.62 Å

PDB-5q3o:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 52)
Method: X-RAY DIFFRACTION / Resolution: 1.6 Å

PDB-5q3p:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 53)
Method: X-RAY DIFFRACTION / Resolution: 1.44 Å

PDB-5q3q:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 54)
Method: X-RAY DIFFRACTION / Resolution: 1.39 Å

PDB-5q3r:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 55)
Method: X-RAY DIFFRACTION / Resolution: 1.5 Å

PDB-5q3s:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 56)
Method: X-RAY DIFFRACTION / Resolution: 1.72 Å

PDB-5q3t:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 57)
Method: X-RAY DIFFRACTION / Resolution: 1.52 Å

PDB-5q3u:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 58)
Method: X-RAY DIFFRACTION / Resolution: 1.49 Å

PDB-5q3v:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 59)
Method: X-RAY DIFFRACTION / Resolution: 1.52 Å

PDB-5q3w:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 60)
Method: X-RAY DIFFRACTION / Resolution: 1.5 Å

PDB-5q3x:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 61)
Method: X-RAY DIFFRACTION / Resolution: 1.38 Å

PDB-5q3y:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 62)
Method: X-RAY DIFFRACTION / Resolution: 1.45 Å

PDB-5q3z:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 63)
Method: X-RAY DIFFRACTION / Resolution: 1.84 Å

PDB-5q40:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 64)
Method: X-RAY DIFFRACTION / Resolution: 2.04 Å

PDB-5q41:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 65)
Method: X-RAY DIFFRACTION / Resolution: 1.95 Å

PDB-5q42:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 66)
Method: X-RAY DIFFRACTION / Resolution: 1.68 Å

PDB-5q43:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 67)
Method: X-RAY DIFFRACTION / Resolution: 1.47 Å

PDB-5q44:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 69)
Method: X-RAY DIFFRACTION / Resolution: 1.55 Å

PDB-5q45:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 70)
Method: X-RAY DIFFRACTION / Resolution: 1.64 Å

PDB-5q46:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 71)
Method: X-RAY DIFFRACTION / Resolution: 2.01 Å

PDB-5q47:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 72)
Method: X-RAY DIFFRACTION / Resolution: 1.38 Å

PDB-5q48:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 73)
Method: X-RAY DIFFRACTION / Resolution: 1.44 Å

PDB-5q49:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 74)
Method: X-RAY DIFFRACTION / Resolution: 1.38 Å

PDB-5q4a:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 75)
Method: X-RAY DIFFRACTION / Resolution: 1.83 Å

PDB-5q4b:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 76)
Method: X-RAY DIFFRACTION / Resolution: 1.6 Å

PDB-5q4c:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 77)
Method: X-RAY DIFFRACTION / Resolution: 2.73 Å

PDB-5q4d:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 78)
Method: X-RAY DIFFRACTION / Resolution: 1.8 Å

PDB-5q4e:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 79)
Method: X-RAY DIFFRACTION / Resolution: 1.39 Å

PDB-5q4f:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 80)
Method: X-RAY DIFFRACTION / Resolution: 1.97 Å

PDB-5q4g:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 81)
Method: X-RAY DIFFRACTION / Resolution: 1.75 Å

PDB-5q4h:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 82)
Method: X-RAY DIFFRACTION / Resolution: 1.53 Å

PDB-5q4i:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 83)
Method: X-RAY DIFFRACTION / Resolution: 1.55 Å

PDB-5q4j:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 84)
Method: X-RAY DIFFRACTION / Resolution: 1.55 Å

PDB-5q4k:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 85)
Method: X-RAY DIFFRACTION / Resolution: 1.47 Å

PDB-5q4l:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 86)
Method: X-RAY DIFFRACTION / Resolution: 1.6 Å

PDB-5q4m:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 87)
Method: X-RAY DIFFRACTION / Resolution: 1.6 Å

PDB-5q4n:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 88)
Method: X-RAY DIFFRACTION / Resolution: 1.71 Å

PDB-5q4o:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 89)
Method: X-RAY DIFFRACTION / Resolution: 1.83 Å

PDB-5q4p:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 90)
Method: X-RAY DIFFRACTION / Resolution: 1.4 Å

PDB-5q4q:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 91)
Method: X-RAY DIFFRACTION / Resolution: 1.42 Å

PDB-5q4r:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 92)
Method: X-RAY DIFFRACTION / Resolution: 2.0 Å

PDB-5q4s:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 93)
Method: X-RAY DIFFRACTION / Resolution: 1.72 Å

PDB-5q4t:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 94)
Method: X-RAY DIFFRACTION / Resolution: 1.77 Å

PDB-5q4u:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 95)
Method: X-RAY DIFFRACTION / Resolution: 2.0 Å

PDB-5q4v:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 96)
Method: X-RAY DIFFRACTION / Resolution: 1.59 Å

PDB-5q4w:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 97)
Method: X-RAY DIFFRACTION / Resolution: 1.8 Å

PDB-5q4x:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 98)
Method: X-RAY DIFFRACTION / Resolution: 1.66 Å

PDB-5q4y:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 99)
Method: X-RAY DIFFRACTION / Resolution: 1.69 Å

PDB-5q4z:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 100)
Method: X-RAY DIFFRACTION / Resolution: 1.6 Å

PDB-5q50:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 101)
Method: X-RAY DIFFRACTION / Resolution: 2.0 Å

PDB-5q51:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 102)
Method: X-RAY DIFFRACTION / Resolution: 1.34 Å

PDB-5q52:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 103)
Method: X-RAY DIFFRACTION / Resolution: 1.7 Å

PDB-5q53:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 104)
Method: X-RAY DIFFRACTION / Resolution: 1.55 Å

PDB-5q54:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 105)
Method: X-RAY DIFFRACTION / Resolution: 1.3 Å

PDB-5q55:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 106)
Method: X-RAY DIFFRACTION / Resolution: 1.39 Å

PDB-5q56:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 107)
Method: X-RAY DIFFRACTION / Resolution: 1.87 Å

PDB-5q57:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 108)
Method: X-RAY DIFFRACTION / Resolution: 1.65 Å

PDB-5q58:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 109)
Method: X-RAY DIFFRACTION / Resolution: 1.75 Å

PDB-5q59:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 110)
Method: X-RAY DIFFRACTION / Resolution: 1.86 Å

PDB-5q5a:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 111)
Method: X-RAY DIFFRACTION / Resolution: 2.26 Å

PDB-5q5b:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 112)
Method: X-RAY DIFFRACTION / Resolution: 1.58 Å

PDB-5q5c:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 113)
Method: X-RAY DIFFRACTION / Resolution: 1.38 Å

PDB-5q5d:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 114)
Method: X-RAY DIFFRACTION / Resolution: 1.71 Å

PDB-5q5e:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 115)
Method: X-RAY DIFFRACTION / Resolution: 1.49 Å

PDB-5q5f:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 116)
Method: X-RAY DIFFRACTION / Resolution: 1.47 Å

PDB-5q5g:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 117)
Method: X-RAY DIFFRACTION / Resolution: 2.0 Å

PDB-5q5h:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 118)
Method: X-RAY DIFFRACTION / Resolution: 1.36 Å

PDB-5q5i:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 119)
Method: X-RAY DIFFRACTION / Resolution: 1.65 Å

PDB-5q5j:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 120)
Method: X-RAY DIFFRACTION / Resolution: 2.0 Å

PDB-5q5k:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 121)
Method: X-RAY DIFFRACTION / Resolution: 2.81 Å

PDB-5q5l:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 122)
Method: X-RAY DIFFRACTION / Resolution: 2.0 Å

PDB-5q5m:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 123)
Method: X-RAY DIFFRACTION / Resolution: 1.57 Å

PDB-5q5n:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 124)
Method: X-RAY DIFFRACTION / Resolution: 2.42 Å

PDB-5q5o:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 125)
Method: X-RAY DIFFRACTION / Resolution: 2.07 Å

PDB-5q5p:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 126)
Method: X-RAY DIFFRACTION / Resolution: 1.58 Å

PDB-5q5q:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 127)
Method: X-RAY DIFFRACTION / Resolution: 1.45 Å

PDB-5q5r:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 128)
Method: X-RAY DIFFRACTION / Resolution: 1.39 Å

PDB-5q5s:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 129)
Method: X-RAY DIFFRACTION / Resolution: 1.7 Å

PDB-5q5t:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 130)
Method: X-RAY DIFFRACTION / Resolution: 1.8 Å

PDB-5q5u:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 131)
Method: X-RAY DIFFRACTION / Resolution: 1.88 Å

PDB-5q5v:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 132)
Method: X-RAY DIFFRACTION / Resolution: 1.86 Å

PDB-5q5w:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 133)
Method: X-RAY DIFFRACTION / Resolution: 1.42 Å

PDB-5q5x:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 134)
Method: X-RAY DIFFRACTION / Resolution: 1.5 Å

PDB-5q5y:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 135)
Method: X-RAY DIFFRACTION / Resolution: 1.82 Å

PDB-5q5z:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 136)
Method: X-RAY DIFFRACTION / Resolution: 1.48 Å

PDB-5q60:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 137)
Method: X-RAY DIFFRACTION / Resolution: 1.4 Å

PDB-5q61:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 138)
Method: X-RAY DIFFRACTION / Resolution: 1.71 Å

PDB-5q62:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 139)
Method: X-RAY DIFFRACTION / Resolution: 1.52 Å

PDB-5q63:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 140)
Method: X-RAY DIFFRACTION / Resolution: 1.82 Å

PDB-5q64:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 141)
Method: X-RAY DIFFRACTION / Resolution: 1.42 Å

PDB-5q65:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 142)
Method: X-RAY DIFFRACTION / Resolution: 1.78 Å

PDB-5q66:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 143)
Method: X-RAY DIFFRACTION / Resolution: 1.51 Å

PDB-5q67:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 144)
Method: X-RAY DIFFRACTION / Resolution: 1.65 Å

PDB-5q68:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 145)
Method: X-RAY DIFFRACTION / Resolution: 1.86 Å

PDB-5q69:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 146)
Method: X-RAY DIFFRACTION / Resolution: 1.84 Å

PDB-5q6a:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 147)
Method: X-RAY DIFFRACTION / Resolution: 1.71 Å

PDB-5q6b:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 148)
Method: X-RAY DIFFRACTION / Resolution: 2.62 Å

PDB-5q6c:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 149)
Method: X-RAY DIFFRACTION / Resolution: 1.53 Å

PDB-5q6d:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 150)
Method: X-RAY DIFFRACTION / Resolution: 1.48 Å

PDB-5q6e:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 151)
Method: X-RAY DIFFRACTION / Resolution: 1.47 Å

PDB-5q6f:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 152)
Method: X-RAY DIFFRACTION / Resolution: 1.55 Å

PDB-5q6g:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 153)
Method: X-RAY DIFFRACTION / Resolution: 1.48 Å

PDB-5q6h:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 154)
Method: X-RAY DIFFRACTION / Resolution: 1.42 Å

PDB-5q6i:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 155)
Method: X-RAY DIFFRACTION / Resolution: 1.68 Å

PDB-5q6j:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 156)
Method: X-RAY DIFFRACTION / Resolution: 1.7 Å

PDB-5q6k:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 157)
Method: X-RAY DIFFRACTION / Resolution: 1.67 Å

PDB-5q6l:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 158)
Method: X-RAY DIFFRACTION / Resolution: 1.82 Å

PDB-5q6m:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 159)
Method: X-RAY DIFFRACTION / Resolution: 1.47 Å

PDB-5q6n:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 160)
Method: X-RAY DIFFRACTION / Resolution: 1.52 Å

PDB-5q6o:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 161)
Method: X-RAY DIFFRACTION / Resolution: 1.4 Å

PDB-5q6p:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 162)
Method: X-RAY DIFFRACTION / Resolution: 1.54 Å

PDB-5q6q:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 163)
Method: X-RAY DIFFRACTION / Resolution: 1.36 Å

PDB-5q6r:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 164)
Method: X-RAY DIFFRACTION / Resolution: 1.42 Å

PDB-5q6s:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 165)
Method: X-RAY DIFFRACTION / Resolution: 1.56 Å

PDB-5q6t:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 166)
Method: X-RAY DIFFRACTION / Resolution: 1.59 Å

PDB-5q6u:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 167)
Method: X-RAY DIFFRACTION / Resolution: 1.33 Å

PDB-5q6v:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 168)
Method: X-RAY DIFFRACTION / Resolution: 1.29 Å

PDB-5q6w:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 169)
Method: X-RAY DIFFRACTION / Resolution: 1.5 Å

PDB-5q6x:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 170)
Method: X-RAY DIFFRACTION / Resolution: 1.43 Å

PDB-5q6y:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 171)
Method: X-RAY DIFFRACTION / Resolution: 1.67 Å

PDB-5q6z:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 172)
Method: X-RAY DIFFRACTION / Resolution: 1.62 Å

PDB-5q70:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 173)
Method: X-RAY DIFFRACTION / Resolution: 1.31 Å

PDB-5q71:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 174)
Method: X-RAY DIFFRACTION / Resolution: 2.0 Å

PDB-5q72:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 175)
Method: X-RAY DIFFRACTION / Resolution: 1.31 Å

PDB-5q73:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 176)
Method: X-RAY DIFFRACTION / Resolution: 1.36 Å

PDB-5q74:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 177)
Method: X-RAY DIFFRACTION / Resolution: 1.21 Å

PDB-5q75:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 178)
Method: X-RAY DIFFRACTION / Resolution: 1.36 Å

PDB-5q76:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 179)
Method: X-RAY DIFFRACTION / Resolution: 1.28 Å

PDB-5q77:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 180)
Method: X-RAY DIFFRACTION / Resolution: 2.0 Å

PDB-5q78:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 181)
Method: X-RAY DIFFRACTION / Resolution: 1.25 Å

PDB-5q79:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 182)
Method: X-RAY DIFFRACTION / Resolution: 1.83 Å

PDB-5q7a:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 183)
Method: X-RAY DIFFRACTION / Resolution: 1.39 Å

PDB-5q7b:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 184)
Method: X-RAY DIFFRACTION / Resolution: 1.25 Å

PDB-5q7c:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 185)
Method: X-RAY DIFFRACTION / Resolution: 1.2 Å

PDB-5q7d:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 186)
Method: X-RAY DIFFRACTION / Resolution: 1.32 Å

PDB-5q7e:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 187)
Method: X-RAY DIFFRACTION / Resolution: 1.5 Å

PDB-5q7f:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 188)
Method: X-RAY DIFFRACTION / Resolution: 1.64 Å

PDB-5q7g:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 189)
Method: X-RAY DIFFRACTION / Resolution: 2.0 Å

PDB-5q7h:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 190)
Method: X-RAY DIFFRACTION / Resolution: 2.0 Å

PDB-5q7i:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 191)
Method: X-RAY DIFFRACTION / Resolution: 1.26 Å

PDB-5q7j:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 192)
Method: X-RAY DIFFRACTION / Resolution: 1.54 Å

PDB-5q7k:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 193)
Method: X-RAY DIFFRACTION / Resolution: 2.0 Å

PDB-5q7l:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 194)
Method: X-RAY DIFFRACTION / Resolution: 1.61 Å

PDB-5q7m:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 195)
Method: X-RAY DIFFRACTION / Resolution: 1.26 Å

PDB-5q7n:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 196)
Method: X-RAY DIFFRACTION / Resolution: 2.0 Å

PDB-5q7o:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 197)
Method: X-RAY DIFFRACTION / Resolution: 1.32 Å

PDB-5q7p:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 198)
Method: X-RAY DIFFRACTION / Resolution: 2.0 Å

PDB-5q7q:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 199)
Method: X-RAY DIFFRACTION / Resolution: 1.76 Å

PDB-5q7r:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 200)
Method: X-RAY DIFFRACTION / Resolution: 1.62 Å

PDB-5q7s:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 201)
Method: X-RAY DIFFRACTION / Resolution: 1.31 Å

PDB-5q7t:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 202)
Method: X-RAY DIFFRACTION / Resolution: 1.67 Å

PDB-5q7u:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 203)
Method: X-RAY DIFFRACTION / Resolution: 2.11 Å

PDB-5q7v:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 204)
Method: X-RAY DIFFRACTION / Resolution: 1.62 Å

PDB-5q7w:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 205)
Method: X-RAY DIFFRACTION / Resolution: 1.27 Å

PDB-5q7x:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 206)
Method: X-RAY DIFFRACTION / Resolution: 1.69 Å

PDB-5q7y:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 207)
Method: X-RAY DIFFRACTION / Resolution: 1.39 Å

PDB-5q7z:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 208)
Method: X-RAY DIFFRACTION / Resolution: 1.65 Å

PDB-5q80:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 209)
Method: X-RAY DIFFRACTION / Resolution: 1.43 Å

PDB-5q81:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 210)
Method: X-RAY DIFFRACTION / Resolution: 1.51 Å

PDB-5q82:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 211)
Method: X-RAY DIFFRACTION / Resolution: 1.2 Å

PDB-5q83:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 212)
Method: X-RAY DIFFRACTION / Resolution: 1.28 Å

PDB-5q84:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 213)
Method: X-RAY DIFFRACTION / Resolution: 1.88 Å

PDB-5q85:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 214)
Method: X-RAY DIFFRACTION / Resolution: 1.8 Å

PDB-5q86:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 215)
Method: X-RAY DIFFRACTION / Resolution: 1.31 Å

PDB-5q87:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 216)
Method: X-RAY DIFFRACTION / Resolution: 1.34 Å

PDB-5q88:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 217)
Method: X-RAY DIFFRACTION / Resolution: 1.78 Å

PDB-5q89:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 218)
Method: X-RAY DIFFRACTION / Resolution: 1.91 Å

PDB-5q8a:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 219)
Method: X-RAY DIFFRACTION / Resolution: 1.43 Å

PDB-5q8b:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 220)
Method: X-RAY DIFFRACTION / Resolution: 1.63 Å

PDB-5q8c:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 221)
Method: X-RAY DIFFRACTION / Resolution: 2.0 Å

PDB-5q8d:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 222)
Method: X-RAY DIFFRACTION / Resolution: 1.23 Å

PDB-5q8e:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 223)
Method: X-RAY DIFFRACTION / Resolution: 1.63 Å

PDB-5q8f:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 224)
Method: X-RAY DIFFRACTION / Resolution: 1.36 Å

PDB-5q8g:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 225)
Method: X-RAY DIFFRACTION / Resolution: 2.0 Å

PDB-5q8h:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 227)
Method: X-RAY DIFFRACTION / Resolution: 1.9 Å

PDB-5q8i:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 228)
Method: X-RAY DIFFRACTION / Resolution: 1.35 Å

PDB-5q8j:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 229)
Method: X-RAY DIFFRACTION / Resolution: 1.79 Å

PDB-5q8k:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 230)
Method: X-RAY DIFFRACTION / Resolution: 1.79 Å

PDB-5q8l:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 231)
Method: X-RAY DIFFRACTION / Resolution: 1.42 Å

PDB-5q8m:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 232)
Method: X-RAY DIFFRACTION / Resolution: 1.71 Å

PDB-5q8n:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 233)
Method: X-RAY DIFFRACTION / Resolution: 1.41 Å

PDB-5q8o:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 234)
Method: X-RAY DIFFRACTION / Resolution: 1.67 Å

PDB-5q8p:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 235)
Method: X-RAY DIFFRACTION / Resolution: 1.45 Å

PDB-5q8q:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 236)
Method: X-RAY DIFFRACTION / Resolution: 1.89 Å

PDB-5q8r:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 237)
Method: X-RAY DIFFRACTION / Resolution: 1.9 Å

PDB-5q8s:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 238)
Method: X-RAY DIFFRACTION / Resolution: 1.61 Å

PDB-5q8t:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 239)
Method: X-RAY DIFFRACTION / Resolution: 2.0 Å

PDB-5q8u:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 240)
Method: X-RAY DIFFRACTION / Resolution: 1.54 Å

PDB-5q8v:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 241)
Method: X-RAY DIFFRACTION / Resolution: 1.32 Å

PDB-5q8w:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 242)
Method: X-RAY DIFFRACTION / Resolution: 1.57 Å

PDB-5q8x:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 243)
Method: X-RAY DIFFRACTION / Resolution: 1.23 Å

PDB-5q8y:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 244)
Method: X-RAY DIFFRACTION / Resolution: 1.51 Å

PDB-5q8z:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 245)
Method: X-RAY DIFFRACTION / Resolution: 1.47 Å

PDB-5q90:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 246)
Method: X-RAY DIFFRACTION / Resolution: 1.49 Å

PDB-5q91:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 247)
Method: X-RAY DIFFRACTION / Resolution: 1.46 Å

PDB-5q92:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 248)
Method: X-RAY DIFFRACTION / Resolution: 2.11 Å

PDB-5q93:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 249)
Method: X-RAY DIFFRACTION / Resolution: 1.68 Å

PDB-5q94:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 250)
Method: X-RAY DIFFRACTION / Resolution: 1.9 Å

PDB-5q95:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 251)
Method: X-RAY DIFFRACTION / Resolution: 1.47 Å

PDB-5q96:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 252)
Method: X-RAY DIFFRACTION / Resolution: 1.83 Å

PDB-5q97:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 253)
Method: X-RAY DIFFRACTION / Resolution: 1.97 Å

PDB-5q98:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 254)
Method: X-RAY DIFFRACTION / Resolution: 1.76 Å

PDB-5q99:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 255)
Method: X-RAY DIFFRACTION / Resolution: 1.31 Å

PDB-5q9a:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 256)
Method: X-RAY DIFFRACTION / Resolution: 1.67 Å

PDB-5q9b:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 257)
Method: X-RAY DIFFRACTION / Resolution: 1.45 Å

PDB-5q9c:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 258)
Method: X-RAY DIFFRACTION / Resolution: 1.46 Å

PDB-5q9d:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 259)
Method: X-RAY DIFFRACTION / Resolution: 1.69 Å

PDB-5q9e:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 260)
Method: X-RAY DIFFRACTION / Resolution: 1.45 Å

PDB-5q9f:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 261)
Method: X-RAY DIFFRACTION / Resolution: 1.28 Å

PDB-5q9g:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 262)
Method: X-RAY DIFFRACTION / Resolution: 1.6 Å

PDB-5q9h:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 263)
Method: X-RAY DIFFRACTION / Resolution: 1.81 Å

PDB-5q9i:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 264)
Method: X-RAY DIFFRACTION / Resolution: 1.46 Å

PDB-5q9j:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 265)
Method: X-RAY DIFFRACTION / Resolution: 1.76 Å

PDB-5q9k:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 266)
Method: X-RAY DIFFRACTION / Resolution: 1.78 Å

PDB-5q9l:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 267)
Method: X-RAY DIFFRACTION / Resolution: 1.59 Å

PDB-5q9m:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 268)
Method: X-RAY DIFFRACTION / Resolution: 1.3 Å

PDB-5q9n:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 269)
Method: X-RAY DIFFRACTION / Resolution: 1.47 Å

PDB-5q9o:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 270)
Method: X-RAY DIFFRACTION / Resolution: 1.37 Å

PDB-5q9p:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 271)
Method: X-RAY DIFFRACTION / Resolution: 1.48 Å

PDB-5q9q:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 272)
Method: X-RAY DIFFRACTION / Resolution: 1.5 Å

PDB-5q9r:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 273)
Method: X-RAY DIFFRACTION / Resolution: 1.72 Å

PDB-5q9s:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 274)
Method: X-RAY DIFFRACTION / Resolution: 1.43 Å

PDB-5q9t:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 275)
Method: X-RAY DIFFRACTION / Resolution: 1.37 Å

PDB-5q9u:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 276)
Method: X-RAY DIFFRACTION / Resolution: 1.49 Å

PDB-5q9v:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 277)
Method: X-RAY DIFFRACTION / Resolution: 1.43 Å

PDB-5q9w:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 278)
Method: X-RAY DIFFRACTION / Resolution: 1.53 Å

PDB-5q9x:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 279)
Method: X-RAY DIFFRACTION / Resolution: 1.67 Å

PDB-5q9y:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 280)
Method: X-RAY DIFFRACTION / Resolution: 1.64 Å

PDB-5q9z:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 281)
Method: X-RAY DIFFRACTION / Resolution: 1.77 Å

PDB-5qa0:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 282)
Method: X-RAY DIFFRACTION / Resolution: 1.47 Å

PDB-5qa1:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 283)
Method: X-RAY DIFFRACTION / Resolution: 1.46 Å

PDB-5qa2:
PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 284)
Method: X-RAY DIFFRACTION / Resolution: 1.56 Å

PDB-5qha:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with PCM-0102951
Method: X-RAY DIFFRACTION / Resolution: 1.57 Å

PDB-5qht:
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000065a
Method: X-RAY DIFFRACTION / Resolution: 1.05 Å

PDB-5qhv:
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000299a
Method: X-RAY DIFFRACTION / Resolution: 1.05 Å

PDB-5qi4:
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000466a
Method: X-RAY DIFFRACTION / Resolution: 1.2 Å

PDB-5qi6:
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000597a
Method: X-RAY DIFFRACTION / Resolution: 1.1 Å

PDB-5qi8:
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000605a
Method: X-RAY DIFFRACTION / Resolution: 1.09 Å

PDB-5qi9:
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000711a
Method: X-RAY DIFFRACTION / Resolution: 1.05 Å

PDB-5qj5:
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with Z44592329
Method: X-RAY DIFFRACTION / Resolution: 1.72 Å

PDB-5qoh:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with XST00000847b
Method: X-RAY DIFFRACTION / Resolution: 1.93 Å

PDB-5qoi:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000213a
Method: X-RAY DIFFRACTION / Resolution: 1.99 Å

PDB-5qoj:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOCR000171b
Method: X-RAY DIFFRACTION / Resolution: 2.05 Å

PDB-5qok:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000294a
Method: X-RAY DIFFRACTION / Resolution: 2.28 Å

PDB-5qol:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000435a
Method: X-RAY DIFFRACTION / Resolution: 1.85 Å

PDB-5qom:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000576a
Method: X-RAY DIFFRACTION / Resolution: 1.87 Å

PDB-5qon:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000446a
Method: X-RAY DIFFRACTION / Resolution: 1.8 Å

PDB-5qoo:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000144a
Method: X-RAY DIFFRACTION / Resolution: 1.56 Å

PDB-5qop:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with NUOOA000023a
Method: X-RAY DIFFRACTION / Resolution: 1.86 Å

PDB-5qoq:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z2895259680
Method: X-RAY DIFFRACTION / Resolution: 1.49 Å

PDB-5qor:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1203490773
Method: X-RAY DIFFRACTION / Resolution: 1.95 Å

PDB-5qos:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1187701032
Method: X-RAY DIFFRACTION / Resolution: 1.7 Å

PDB-5qot:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1592710382
Method: X-RAY DIFFRACTION / Resolution: 1.68 Å

PDB-5qou:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z296300542
Method: X-RAY DIFFRACTION / Resolution: 2.19 Å

PDB-5qov:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1699011516
Method: X-RAY DIFFRACTION / Resolution: 1.65 Å

PDB-5qow:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z2895259675
Method: X-RAY DIFFRACTION / Resolution: 1.82 Å

PDB-5qox:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z2212124043
Method: X-RAY DIFFRACTION / Resolution: 1.95 Å

PDB-5qoy:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with YW-FY-378
Method: X-RAY DIFFRACTION / Resolution: 1.69 Å

PDB-5qoz:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with PB1787571279
Method: X-RAY DIFFRACTION / Resolution: 1.7 Å

PDB-5qp0:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z454376544
Method: X-RAY DIFFRACTION / Resolution: 2.0 Å

PDB-5qp1:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1190363272
Method: X-RAY DIFFRACTION / Resolution: 1.79 Å

PDB-5qp2:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1170065264
Method: X-RAY DIFFRACTION / Resolution: 1.83 Å

PDB-5qp3:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1494850193
Method: X-RAY DIFFRACTION / Resolution: 1.75 Å

PDB-5qp4:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z450133538
Method: X-RAY DIFFRACTION / Resolution: 1.71 Å

PDB-5qp5:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z2895259681
Method: X-RAY DIFFRACTION / Resolution: 1.9 Å

PDB-5qp6:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1662802141
Method: X-RAY DIFFRACTION / Resolution: 1.65 Å

PDB-5qp7:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with PB1230873739
Method: X-RAY DIFFRACTION / Resolution: 1.88 Å

PDB-5qp8:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with PB1787571279
Method: X-RAY DIFFRACTION / Resolution: 1.64 Å

PDB-5qp9:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z100435060
Method: X-RAY DIFFRACTION / Resolution: 1.72 Å

PDB-5qpa:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000449a
Method: X-RAY DIFFRACTION / Resolution: 1.61 Å

PDB-5qpb:
PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000701a
Method: X-RAY DIFFRACTION / Resolution: 1.68 Å

PDB-5qqd:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with Z56880342
Method: X-RAY DIFFRACTION / Resolution: 1.91 Å

PDB-5qqe:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-531-494
Method: X-RAY DIFFRACTION / Resolution: 1.95 Å

PDB-5qqf:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-004-412-710
Method: X-RAY DIFFRACTION / Resolution: 2.26 Å

PDB-5qqg:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-541-216
Method: X-RAY DIFFRACTION / Resolution: 2.23 Å

PDB-5qqh:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-020-096-465
Method: X-RAY DIFFRACTION / Resolution: 2.09 Å

PDB-5qqi:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-178-994
Method: X-RAY DIFFRACTION / Resolution: 2.08 Å

PDB-5qqj:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-587-558
Method: X-RAY DIFFRACTION / Resolution: 1.9 Å

PDB-5qqk:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-359-835
Method: X-RAY DIFFRACTION / Resolution: 2.24 Å

PDB-5qql:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-565-301
Method: X-RAY DIFFRACTION / Resolution: 2.25 Å

PDB-5qqm:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-009-565-325
Method: X-RAY DIFFRACTION / Resolution: 2.02 Å

PDB-5qqn:
PanDDA analysis group deposition -- Crystal Structure of Kalirin/Rac1 in complex with MolPort-010-382-606
Method: X-RAY DIFFRACTION / Resolution: 2.26 Å

PDB-5qqq:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2856434857
Method: X-RAY DIFFRACTION / Resolution: 1.93 Å

PDB-5qqr:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1171217421
Method: X-RAY DIFFRACTION / Resolution: 1.46 Å

PDB-5qqs:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z275151340
Method: X-RAY DIFFRACTION / Resolution: 1.85 Å

PDB-5qqt:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2856434834
Method: X-RAY DIFFRACTION / Resolution: 1.67 Å

PDB-5qqu:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1348371854
Method: X-RAY DIFFRACTION / Resolution: 1.55 Å

PDB-5qqv:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1545312521
Method: X-RAY DIFFRACTION / Resolution: 1.52 Å

PDB-5qqw:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z136583524
Method: X-RAY DIFFRACTION / Resolution: 1.56 Å

PDB-5qqx:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z373768900
Method: X-RAY DIFFRACTION / Resolution: 1.5 Å

PDB-5qqy:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2856434899
Method: X-RAY DIFFRACTION / Resolution: 1.49 Å

PDB-5qqz:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1675346324
Method: X-RAY DIFFRACTION / Resolution: 1.55 Å

PDB-5qr0:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z730649594
Method: X-RAY DIFFRACTION / Resolution: 1.65 Å

PDB-5qr1:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z396380540
Method: X-RAY DIFFRACTION / Resolution: 1.44 Å

PDB-5qr2:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1348371854
Method: X-RAY DIFFRACTION / Resolution: 1.66 Å

PDB-5qr3:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z915492990
Method: X-RAY DIFFRACTION / Resolution: 1.71 Å

PDB-5qr4:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2856434826
Method: X-RAY DIFFRACTION / Resolution: 1.57 Å

PDB-5qr5:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2241115980
Method: X-RAY DIFFRACTION / Resolution: 1.49 Å

PDB-5qr6:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z44567722
Method: X-RAY DIFFRACTION / Resolution: 1.52 Å

PDB-5qr7:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z57299529
Method: X-RAY DIFFRACTION / Resolution: 1.74 Å

PDB-5qr8:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z57258487
Method: X-RAY DIFFRACTION / Resolution: 1.85 Å

PDB-5qr9:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z31478129
Method: X-RAY DIFFRACTION / Resolution: 1.62 Å

PDB-5qra:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1101755952
Method: X-RAY DIFFRACTION / Resolution: 1.72 Å

PDB-5qrb:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2856434868
Method: X-RAY DIFFRACTION / Resolution: 1.72 Å

PDB-5qrc:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z31721798
Method: X-RAY DIFFRACTION / Resolution: 1.82 Å

PDB-5qrd:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1328968520
Method: X-RAY DIFFRACTION / Resolution: 1.76 Å

PDB-5qre:
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z117233350
Method: X-RAY DIFFRACTION / Resolution: 1.67 Å

PDB-5qrf:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z373768900
Method: X-RAY DIFFRACTION / Resolution: 2.03 Å

PDB-5qrg:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z275151340
Method: X-RAY DIFFRACTION / Resolution: 1.95 Å

PDB-5qrh:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z32327641
Method: X-RAY DIFFRACTION / Resolution: 1.81 Å

PDB-5qri:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z2856434826
Method: X-RAY DIFFRACTION / Resolution: 1.83 Å

PDB-5qrj:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z416341642
Method: X-RAY DIFFRACTION / Resolution: 1.81 Å

PDB-5qrk:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z275179758
Method: X-RAY DIFFRACTION / Resolution: 1.63 Å

PDB-5qrl:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z437516460
Method: X-RAY DIFFRACTION / Resolution: 1.76 Å

PDB-5qrm:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1899842917
Method: X-RAY DIFFRACTION / Resolution: 1.55 Å

PDB-5qrn:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z54226006
Method: X-RAY DIFFRACTION / Resolution: 1.62 Å

PDB-5qro:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1506050651
Method: X-RAY DIFFRACTION / Resolution: 1.61 Å

PDB-5qrp:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z2442270563
Method: X-RAY DIFFRACTION / Resolution: 1.67 Å

PDB-5qrq:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z645232558
Method: X-RAY DIFFRACTION / Resolution: 2.1 Å

PDB-5qrr:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z31720228
Method: X-RAY DIFFRACTION / Resolution: 1.69 Å

PDB-5qrs:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1891773393
Method: X-RAY DIFFRACTION / Resolution: 2.06 Å

PDB-5qrt:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z31735562
Method: X-RAY DIFFRACTION / Resolution: 1.77 Å

PDB-5qru:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z235341991
Method: X-RAY DIFFRACTION / Resolution: 1.76 Å

PDB-5qrv:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z198194396
Method: X-RAY DIFFRACTION / Resolution: 1.67 Å

PDB-5qrw:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1509882419
Method: X-RAY DIFFRACTION / Resolution: 1.74 Å

PDB-5qrx:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z364328788
Method: X-RAY DIFFRACTION / Resolution: 1.87 Å

PDB-5qry:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z2856434890
Method: X-RAY DIFFRACTION / Resolution: 1.58 Å

PDB-5qrz:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1998104358
Method: X-RAY DIFFRACTION / Resolution: 1.96 Å

PDB-5qs0:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z274555794
Method: X-RAY DIFFRACTION / Resolution: 1.6 Å

PDB-5qs1:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1954800564
Method: X-RAY DIFFRACTION / Resolution: 1.66 Å

PDB-5qs2:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z291279160
Method: X-RAY DIFFRACTION / Resolution: 1.68 Å

PDB-5qs3:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z198195770
Method: X-RAY DIFFRACTION / Resolution: 1.71 Å

PDB-5qs4:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z30820160
Method: X-RAY DIFFRACTION / Resolution: 1.65 Å

PDB-5qs5:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z32400357
Method: X-RAY DIFFRACTION / Resolution: 1.81 Å

PDB-5qs6:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z44592329
Method: X-RAY DIFFRACTION / Resolution: 1.67 Å

PDB-5qs7:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z32327641
Method: X-RAY DIFFRACTION / Resolution: 1.66 Å

PDB-5qs8:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z1432018343
Method: X-RAY DIFFRACTION / Resolution: 1.47 Å

PDB-5qs9:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z48847594
Method: X-RAY DIFFRACTION / Resolution: 1.43 Å

PDB-5qsa:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434778
Method: X-RAY DIFFRACTION / Resolution: 1.55 Å

PDB-5qsb:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434874
Method: X-RAY DIFFRACTION / Resolution: 1.82 Å

PDB-5qsc:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z300245038
Method: X-RAY DIFFRACTION / Resolution: 1.62 Å

PDB-5qsd:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z54571979
Method: X-RAY DIFFRACTION / Resolution: 1.87 Å

PDB-5qse:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2017168803
Method: X-RAY DIFFRACTION / Resolution: 2.01 Å

PDB-5qsf:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434814
Method: X-RAY DIFFRACTION / Resolution: 1.96 Å

PDB-5qsg:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434903
Method: X-RAY DIFFRACTION / Resolution: 1.87 Å

PDB-5qsh:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434868
Method: X-RAY DIFFRACTION / Resolution: 1.9 Å

PDB-5qsi:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z933326822
Method: X-RAY DIFFRACTION / Resolution: 1.64 Å

PDB-5qsj:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z198194394
Method: X-RAY DIFFRACTION / Resolution: 1.49 Å

PDB-5qsk:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434906
Method: X-RAY DIFFRACTION / Resolution: 1.55 Å

PDB-5qsl:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1273312153
Method: X-RAY DIFFRACTION / Resolution: 2.2 Å

PDB-5qsm:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z57261895
Method: X-RAY DIFFRACTION / Resolution: 2.74 Å

PDB-5qsn:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z1272480091
Method: X-RAY DIFFRACTION / Resolution: 2.66 Å

PDB-5qso:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z466628048
Method: X-RAY DIFFRACTION / Resolution: 2.7 Å

PDB-5qsp:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2856434929
Method: X-RAY DIFFRACTION / Resolution: 2.89 Å

PDB-5qsq:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z396380540
Method: X-RAY DIFFRACTION / Resolution: 2.48 Å

PDB-5qsr:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z136583524
Method: X-RAY DIFFRACTION / Resolution: 3.28 Å

PDB-5qss:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z33452282
Method: X-RAY DIFFRACTION / Resolution: 3.08 Å

PDB-5qst:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2447286438
Method: X-RAY DIFFRACTION / Resolution: 2.58 Å

PDB-5qsu:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2856434926
Method: X-RAY DIFFRACTION / Resolution: 2.73 Å

PDB-5qsv:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2856434783
Method: X-RAY DIFFRACTION / Resolution: 2.76 Å

PDB-5qsw:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2856434884
Method: X-RAY DIFFRACTION / Resolution: 3.03 Å

PDB-5qsx:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2856434812
Method: X-RAY DIFFRACTION / Resolution: 2.34 Å

PDB-5qsy:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z755044716
Method: X-RAY DIFFRACTION / Resolution: 2.4 Å

PDB-5qsz:
PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z1267773786
Method: X-RAY DIFFRACTION / Resolution: 3.08 Å

PDB-5qt0:
PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z321318226
Method: X-RAY DIFFRACTION / Resolution: 2.1 Å

PDB-5qt1:
PanDDA analysis group deposition -- Partial occupancy interpretation of PanDDA event map: SETDB1 in complex with FMOMB000017a
Method: X-RAY DIFFRACTION / Resolution: 1.58 Å

PDB-5qt2:
PanDDA analysis group deposition -- Partial occupancy interpretation of PanDDA event map: SETDB1 in complex with FMOPL000074a
Method: X-RAY DIFFRACTION / Resolution: 1.59 Å

PDB-5qtl:
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with GB-0804
Method: X-RAY DIFFRACTION / Resolution: 1.73 Å

PDB-5qtm:
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with FS-2639
Method: X-RAY DIFFRACTION / Resolution: 1.79 Å

PDB-5qtn:
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with SS-4432
Method: X-RAY DIFFRACTION / Resolution: 1.83 Å

PDB-5qto:
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with 1R-0641
Method: X-RAY DIFFRACTION / Resolution: 1.67 Å

PDB-5qtp:
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with AE-0227
Method: X-RAY DIFFRACTION / Resolution: 1.73 Å

PDB-5qtq:
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with FS-1169
Method: X-RAY DIFFRACTION / Resolution: 1.82 Å

PDB-5qtr:
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with FS-3764
Method: X-RAY DIFFRACTION / Resolution: 1.55 Å

PDB-5qts:
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with 8J-537S
Method: X-RAY DIFFRACTION / Resolution: 1.85 Å

PDB-5r4g:
PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000621a
Method: X-RAY DIFFRACTION / Resolution: 1.25 Å

PDB-5r4h:
PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000287a
Method: X-RAY DIFFRACTION / Resolution: 1.18 Å

PDB-5r4i:
PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000443a
Method: X-RAY DIFFRACTION / Resolution: 1.28 Å

PDB-5r4j:
PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000280a
Method: X-RAY DIFFRACTION / Resolution: 1.39 Å

PDB-5r4k:
PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000292a
Method: X-RAY DIFFRACTION / Resolution: 1.17 Å

PDB-5r4l:
PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000349a
Method: X-RAY DIFFRACTION / Resolution: 1.13 Å

PDB-5r4m:
PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000513a
Method: X-RAY DIFFRACTION / Resolution: 1.11 Å

PDB-5r4n:
PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000061a
Method: X-RAY DIFFRACTION / Resolution: 1.28 Å

PDB-5r4p:
PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with NM450-1
Method: X-RAY DIFFRACTION / Resolution: 1.78 Å

PDB-5r4q:
PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with NM466-1
Method: X-RAY DIFFRACTION / Resolution: 1.49 Å

PDB-5r4r:
PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with EN08775-42
Method: X-RAY DIFFRACTION / Resolution: 1.5 Å

PDB-5r4s:
PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with EN08775-45
Method: X-RAY DIFFRACTION / Resolution: 1.61 Å

PDB-5r4t:
PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with SK-430
Method: X-RAY DIFFRACTION / Resolution: 1.68 Å

PDB-5r4u:
PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with EN08775-43
Method: X-RAY DIFFRACTION / Resolution: 1.92 Å

PDB-5r50:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13371a
Method: X-RAY DIFFRACTION / Resolution: 1.87 Å

PDB-5r51:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14003a
Method: X-RAY DIFFRACTION / Resolution: 1.65 Å

PDB-5r52:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14004a
Method: X-RAY DIFFRACTION / Resolution: 1.48 Å

PDB-5r53:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13854a
Method: X-RAY DIFFRACTION / Resolution: 1.4 Å

PDB-5r54:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13582a
Method: X-RAY DIFFRACTION / Resolution: 1.79 Å

PDB-5r55:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13369a
Method: X-RAY DIFFRACTION / Resolution: 1.48 Å

PDB-5r56:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13688a
Method: X-RAY DIFFRACTION / Resolution: 1.51 Å

PDB-5r57:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N08253b
Method: X-RAY DIFFRACTION / Resolution: 1.44 Å

PDB-5r58:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13542a
Method: X-RAY DIFFRACTION / Resolution: 1.98 Å

PDB-5r59:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13441a
Method: X-RAY DIFFRACTION / Resolution: 2.11 Å

PDB-5r5a:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13663a
Method: X-RAY DIFFRACTION / Resolution: 1.44 Å

PDB-5r5b:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13725a
Method: X-RAY DIFFRACTION / Resolution: 1.53 Å

PDB-5r5c:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13956a
Method: X-RAY DIFFRACTION / Resolution: 1.68 Å

PDB-5r5d:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13564a
Method: X-RAY DIFFRACTION / Resolution: 1.65 Å

PDB-5r5e:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13848a
Method: X-RAY DIFFRACTION / Resolution: 1.58 Å

PDB-5r5f:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13793a
Method: X-RAY DIFFRACTION / Resolution: 1.63 Å

PDB-5r5g:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13707a
Method: X-RAY DIFFRACTION / Resolution: 1.77 Å

PDB-5r5h:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13706a
Method: X-RAY DIFFRACTION / Resolution: 1.79 Å

PDB-5r5i:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N06325b
Method: X-RAY DIFFRACTION / Resolution: 1.7 Å

PDB-5r5j:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13964a
Method: X-RAY DIFFRACTION / Resolution: 1.98 Å

PDB-5r5k:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13960a
Method: X-RAY DIFFRACTION / Resolution: 1.6 Å

PDB-5r5l:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13589a
Method: X-RAY DIFFRACTION / Resolution: 1.63 Å

PDB-5r5m:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14123a
Method: X-RAY DIFFRACTION / Resolution: 1.6 Å

PDB-5r5n:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13595a
Method: X-RAY DIFFRACTION / Resolution: 1.87 Å

PDB-5r5o:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14027a
Method: X-RAY DIFFRACTION / Resolution: 1.79 Å

PDB-5r5p:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13910a
Method: X-RAY DIFFRACTION / Resolution: 1.53 Å

PDB-5r5q:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13920a
Method: X-RAY DIFFRACTION / Resolution: 1.71 Å

PDB-5r5r:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14078a
Method: X-RAY DIFFRACTION / Resolution: 1.65 Å

PDB-5r5s:
PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13775a
Method: X-RAY DIFFRACTION / Resolution: 1.5 Å

PDB-5r5t:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z1251207602
Method: X-RAY DIFFRACTION / Resolution: 1.55 Å

PDB-5r5u:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z1545312521
Method: X-RAY DIFFRACTION / Resolution: 1.52 Å

PDB-5r5v:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z2856434824
Method: X-RAY DIFFRACTION / Resolution: 1.7 Å

PDB-5r5w:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z2856434942
Method: X-RAY DIFFRACTION / Resolution: 1.6 Å

PDB-5r5x:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z1259335913
Method: X-RAY DIFFRACTION / Resolution: 1.56 Å

PDB-5r5y:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z509756472
Method: X-RAY DIFFRACTION / Resolution: 1.57 Å

PDB-5r5z:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z2856434821
Method: X-RAY DIFFRACTION / Resolution: 1.67 Å

PDB-5r60:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z19735067
Method: X-RAY DIFFRACTION / Resolution: 1.79 Å

PDB-5r61:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z1578665941
Method: X-RAY DIFFRACTION / Resolution: 1.38 Å

PDB-5r62:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z2856434840
Method: X-RAY DIFFRACTION / Resolution: 1.4 Å

PDB-5r63:
PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z319545618
Method: X-RAY DIFFRACTION / Resolution: 1.59 Å

PDB-5r64:
PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with FMOPL000464a
Method: X-RAY DIFFRACTION / Resolution: 1.84 Å

PDB-5r65:
PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with FMOPL000387a
Method: X-RAY DIFFRACTION / Resolution: 2.28 Å

PDB-5r66:
PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with FMOPL000198a
Method: X-RAY DIFFRACTION / Resolution: 2.02 Å

PDB-5r67:
PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with FMOPL000589a
Method: X-RAY DIFFRACTION / Resolution: 1.52 Å

PDB-5rhg:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z235341991
Method: X-RAY DIFFRACTION / Resolution: 1.41 Å

PDB-5rhh:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1515654336
Method: X-RAY DIFFRACTION / Resolution: 1.59 Å

PDB-5rhi:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z198194396
Method: X-RAY DIFFRACTION / Resolution: 1.45 Å

PDB-5rhj:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z126932614
Method: X-RAY DIFFRACTION / Resolution: 1.5 Å

PDB-5rhk:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z87615031
Method: X-RAY DIFFRACTION / Resolution: 1.52 Å

PDB-5rhl:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z425387594
Method: X-RAY DIFFRACTION / Resolution: 1.43 Å

PDB-5rhm:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1454310449
Method: X-RAY DIFFRACTION / Resolution: 1.68 Å

PDB-5rho:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1444783243
Method: X-RAY DIFFRACTION / Resolution: 1.49 Å

PDB-5rhp:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z2856434938
Method: X-RAY DIFFRACTION / Resolution: 1.61 Å

PDB-5rhq:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z235449082
Method: X-RAY DIFFRACTION / Resolution: 1.49 Å

PDB-5rhr:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1348559502
Method: X-RAY DIFFRACTION / Resolution: 1.46 Å

PDB-5rhs:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z274555794
Method: X-RAY DIFFRACTION / Resolution: 1.53 Å

PDB-5rht:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z291279160
Method: X-RAY DIFFRACTION / Resolution: 1.63 Å

PDB-5rhu:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1703168683
Method: X-RAY DIFFRACTION / Resolution: 1.61 Å

PDB-5rhv:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z62645406
Method: X-RAY DIFFRACTION / Resolution: 1.71 Å

PDB-5rhw:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z31222641
Method: X-RAY DIFFRACTION / Resolution: 1.62 Å

PDB-5rhx:
PanDDA analysis group deposition -- Crystal Structure of Zika virus NS3 Helicase in complex with Z1324080698
Method: X-RAY DIFFRACTION / Resolution: 1.73 Å

PDB-5rvw:
PanDDA analysis group deposition -- Crystal Structure of DHTKD1 in complex with Z1587220559
Method: X-RAY DIFFRACTION / Resolution: 1.614 Å

PDB-5rvx:
PanDDA analysis group deposition -- Crystal Structure of DHTKD1 in complex with Z804566442
Method: X-RAY DIFFRACTION / Resolution: 1.661 Å

PDB-5rvy:
PanDDA analysis group deposition -- Crystal Structure of DHTKD1 in complex with Z437516460
Method: X-RAY DIFFRACTION / Resolution: 1.609 Å

PDB-5rvz:
PanDDA analysis group deposition -- Crystal Structure of DHTKD1 in complex with Z1929757385
Method: X-RAY DIFFRACTION / Resolution: 1.98 Å

PDB-5rw0:
PanDDA analysis group deposition -- Crystal Structure of DHTKD1 in complex with Z2444997446
Method: X-RAY DIFFRACTION / Resolution: 1.673 Å

PDB-5s6x:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2889976755
Method: X-RAY DIFFRACTION / Resolution: 2.32 Å

PDB-5s6y:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z56900771
Method: X-RAY DIFFRACTION / Resolution: 2.32 Å

PDB-5s6z:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with PB2255187532
Method: X-RAY DIFFRACTION / Resolution: 2.28 Å

PDB-5s70:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-181428
Method: X-RAY DIFFRACTION / Resolution: 2.327 Å

PDB-5s71:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with FUZS-5
Method: X-RAY DIFFRACTION / Resolution: 1.941 Å

PDB-5s72:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with BBL029427
Method: X-RAY DIFFRACTION / Resolution: 2.512 Å

PDB-5s9s:
PanDDA analysis group deposition -- Crystal Structure of Trypanosoma brucei Trypanothione reductase in complex with Z2856434898
Method: X-RAY DIFFRACTION / Resolution: 1.8 Å

PDB-5s9t:
PanDDA analysis group deposition -- Crystal Structure of Trypanosoma brucei Trypanothione reductase in complex with Z1614545742
Method: X-RAY DIFFRACTION / Resolution: 1.66 Å

PDB-5s9u:
PanDDA analysis group deposition -- Crystal Structure of Trypanosoma brucei Trypanothione reductase in complex with Z32327641
Method: X-RAY DIFFRACTION / Resolution: 1.73 Å

PDB-5s9v:
PanDDA analysis group deposition -- Crystal Structure of Trypanosoma brucei Trypanothione reductase in complex with Z2856434826
Method: X-RAY DIFFRACTION / Resolution: 1.9 Å

PDB-5s9w:
PanDDA analysis group deposition -- Crystal Structure of Trypanosoma brucei Trypanothione reductase in complex with Z26769872
Method: X-RAY DIFFRACTION / Resolution: 1.96 Å

PDB-5s9x:
PanDDA analysis group deposition -- Crystal Structure of Trypanosoma brucei Trypanothione reductase in complex with Z1899842917
Method: X-RAY DIFFRACTION / Resolution: 1.84 Å

PDB-5s9y:
PanDDA analysis group deposition -- Crystal Structure of Trypanosoma brucei Trypanothione reductase in complex with Z24758179
Method: X-RAY DIFFRACTION / Resolution: 1.75 Å

PDB-5s9z:
PanDDA analysis group deposition -- Crystal Structure of Trypanosoma brucei Trypanothione reductase in complex with Z2856434884
Method: X-RAY DIFFRACTION / Resolution: 1.73 Å

PDB-5sa0:
PanDDA analysis group deposition -- Crystal Structure of Trypanosoma brucei Trypanothione reductase in complex with Z1506050651
Method: X-RAY DIFFRACTION / Resolution: 1.97 Å

PDB-5sa1:
PanDDA analysis group deposition -- Crystal Structure of Trypanosoma brucei Trypanothione reductase in complex with Z2856434944
Method: X-RAY DIFFRACTION / Resolution: 1.84 Å

PDB-5sa2:
PanDDA analysis group deposition -- Crystal Structure of Trypanosoma brucei Trypanothione reductase in complex with Z1148747945
Method: X-RAY DIFFRACTION / Resolution: 1.78 Å

PDB-5sa3:
PanDDA analysis group deposition -- Crystal Structure of Trypanosoma brucei Trypanothione reductase in complex with Z2856434874
Method: X-RAY DIFFRACTION / Resolution: 1.74 Å

PDB-5sa4:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z239136710
Method: X-RAY DIFFRACTION / Resolution: 2.046 Å

PDB-5sa5:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1530301542
Method: X-RAY DIFFRACTION / Resolution: 2.09 Å

PDB-5sa6:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2856434783
Method: X-RAY DIFFRACTION / Resolution: 2.517 Å

PDB-5sa7:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1673618163
Method: X-RAY DIFFRACTION / Resolution: 2.222 Å

PDB-5sa8:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z68299550
Method: X-RAY DIFFRACTION / Resolution: 2.298 Å

PDB-5sa9:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2697514548
Method: X-RAY DIFFRACTION / Resolution: 1.92 Å

PDB-5saa:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z319891284
Method: X-RAY DIFFRACTION / Resolution: 2.239 Å

PDB-5sab:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z31504642
Method: X-RAY DIFFRACTION / Resolution: 2.486 Å

PDB-5sac:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z59181945
Method: X-RAY DIFFRACTION / Resolution: 2.029 Å

PDB-5sad:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z425449682
Method: X-RAY DIFFRACTION / Resolution: 1.961 Å

PDB-5sae:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z3219959731
Method: X-RAY DIFFRACTION / Resolution: 2.12 Å

PDB-5saf:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-321461
Method: X-RAY DIFFRACTION / Resolution: 2.11 Å

PDB-5sag:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-1605072
Method: X-RAY DIFFRACTION / Resolution: 1.881 Å

PDB-5sah:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-100112
Method: X-RAY DIFFRACTION / Resolution: 2.16 Å

PDB-5sai:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1424343998
Method: X-RAY DIFFRACTION / Resolution: 2.022 Å

PDB-5sdc:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z2856434912
Method: X-RAY DIFFRACTION / Resolution: 1.928 Å

PDB-5sdd:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z2856434879
Method: X-RAY DIFFRACTION / Resolution: 1.839 Å

PDB-5sde:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z1619978933
Method: X-RAY DIFFRACTION / Resolution: 1.854 Å

PDB-5sdf:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z2856434834
Method: X-RAY DIFFRACTION / Resolution: 1.877 Å

PDB-5sdg:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z136583524
Method: X-RAY DIFFRACTION / Resolution: 1.95 Å

PDB-5sdh:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z2856434854
Method: X-RAY DIFFRACTION / Resolution: 2.313 Å

PDB-5sdi:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z44592329
Method: X-RAY DIFFRACTION / Resolution: 1.898 Å

PDB-5sdj:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z32327641
Method: X-RAY DIFFRACTION / Resolution: 2.041 Å

PDB-5sdk:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z416341642
Method: X-RAY DIFFRACTION / Resolution: 1.977 Å

PDB-5sdl:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z321318226
Method: X-RAY DIFFRACTION / Resolution: 2.44 Å

PDB-5sdm:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z1328078283
Method: X-RAY DIFFRACTION / Resolution: 2.039 Å

PDB-5sdn:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z437584380
Method: X-RAY DIFFRACTION / Resolution: 2.023 Å

PDB-5sdo:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z19735067
Method: X-RAY DIFFRACTION / Resolution: 2.051 Å

PDB-5sdp:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z2277255954
Method: X-RAY DIFFRACTION / Resolution: 2.195 Å

PDB-5sdq:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z2856434887
Method: X-RAY DIFFRACTION / Resolution: 1.92 Å

PDB-5sdr:
PanDDA analysis group deposition -- Crystal Structure of Porphyromonas gingivalis in complex with Z1273312153
Method: X-RAY DIFFRACTION / Resolution: 2.077 Å

PDB-5skw:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1272494722
Method: X-RAY DIFFRACTION / Resolution: 2.093 Å

PDB-5skx:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z126932614
Method: X-RAY DIFFRACTION / Resolution: 2.342 Å

PDB-5sky:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z466628048
Method: X-RAY DIFFRACTION / Resolution: 2.25 Å

PDB-5skz:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z57258487
Method: X-RAY DIFFRACTION / Resolution: 1.96 Å

PDB-5sl0:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z57260516
Method: X-RAY DIFFRACTION / Resolution: 2.001 Å

PDB-5sl1:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1273312153
Method: X-RAY DIFFRACTION / Resolution: 2.383 Å

PDB-5sl2:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z100643660
Method: X-RAY DIFFRACTION / Resolution: 1.739 Å

PDB-5sl3:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z223688272
Method: X-RAY DIFFRACTION / Resolution: 1.99 Å

PDB-5sl4:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z383202616
Method: X-RAY DIFFRACTION / Resolution: 1.936 Å

PDB-5sl5:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z32014663
Method: X-RAY DIFFRACTION / Resolution: 2.36 Å

PDB-5sl6:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z256709556
Method: X-RAY DIFFRACTION / Resolution: 2.289 Å

PDB-5sl7:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1186029914
Method: X-RAY DIFFRACTION / Resolution: 1.841 Å

PDB-5sl8:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434762
Method: X-RAY DIFFRACTION / Resolution: 2.07 Å

PDB-5sl9:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z54571979
Method: X-RAY DIFFRACTION / Resolution: 1.749 Å

PDB-5sla:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1003207278
Method: X-RAY DIFFRACTION / Resolution: 1.7 Å

PDB-5slb:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z744930860
Method: X-RAY DIFFRACTION / Resolution: 1.8 Å

PDB-5slc:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1849009686
Method: X-RAY DIFFRACTION / Resolution: 1.668 Å

PDB-5sld:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1246465616
Method: X-RAY DIFFRACTION / Resolution: 1.581 Å

PDB-5sle:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z56880342
Method: X-RAY DIFFRACTION / Resolution: 2.009 Å

PDB-5slf:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z198195770
Method: X-RAY DIFFRACTION / Resolution: 2.01 Å

PDB-5slg:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z32400357
Method: X-RAY DIFFRACTION / Resolution: 1.97 Å

PDB-5slh:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z65532537
Method: X-RAY DIFFRACTION / Resolution: 1.819 Å

PDB-5sli:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1003146540
Method: X-RAY DIFFRACTION / Resolution: 2.3 Å

PDB-5slj:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1430613393
Method: X-RAY DIFFRACTION / Resolution: 2.31 Å

PDB-5slk:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1354370680
Method: X-RAY DIFFRACTION / Resolution: 2.21 Å

PDB-5sll:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z54615640
Method: X-RAY DIFFRACTION / Resolution: 1.807 Å

PDB-5slm:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z28290384
Method: X-RAY DIFFRACTION / Resolution: 2.05 Å

PDB-5sln:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z57299529
Method: X-RAY DIFFRACTION / Resolution: 2.208 Å

PDB-5slo:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z56983806
Method: X-RAY DIFFRACTION / Resolution: 1.829 Å

PDB-5slp:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z373768898
Method: X-RAY DIFFRACTION / Resolution: 1.819 Å

PDB-5slq:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434829
Method: X-RAY DIFFRACTION / Resolution: 2.112 Å

PDB-5slr:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2073741691
Method: X-RAY DIFFRACTION / Resolution: 1.86 Å

PDB-5sls:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1373445602
Method: X-RAY DIFFRACTION / Resolution: 2.29 Å

PDB-5slt:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1816233707
Method: X-RAY DIFFRACTION / Resolution: 1.901 Å

PDB-5slu:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1796014543
Method: X-RAY DIFFRACTION / Resolution: 2.09 Å

PDB-5slv:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434942
Method: X-RAY DIFFRACTION / Resolution: 2.049 Å

PDB-5slw:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1310876699
Method: X-RAY DIFFRACTION / Resolution: 2.05 Å

PDB-5slx:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z752989138
Method: X-RAY DIFFRACTION / Resolution: 1.76 Å

PDB-5sly:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1526504764
Method: X-RAY DIFFRACTION / Resolution: 2.018 Å

PDB-5slz:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2072621991
Method: X-RAY DIFFRACTION / Resolution: 2.54 Å

PDB-5sm0:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z32665176
Method: X-RAY DIFFRACTION / Resolution: 2.086 Å

PDB-5sm1:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z68277692
Method: X-RAY DIFFRACTION / Resolution: 1.941 Å

PDB-5sm2:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z3006151474
Method: X-RAY DIFFRACTION / Resolution: 1.781 Å

PDB-5sm3:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z943693514
Method: X-RAY DIFFRACTION / Resolution: 2.198 Å

PDB-5sm4:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434944
Method: X-RAY DIFFRACTION / Resolution: 2.16 Å

PDB-5sm5:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434807
Method: X-RAY DIFFRACTION / Resolution: 1.95 Å

PDB-5sm6:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1899842917
Method: X-RAY DIFFRACTION / Resolution: 2.29 Å

PDB-5sm7:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z1247413608
Method: X-RAY DIFFRACTION / Resolution: 1.95 Å

PDB-5sm8:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2027158783
Method: X-RAY DIFFRACTION / Resolution: 1.95 Å

PDB-5sm9:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2234920345
Method: X-RAY DIFFRACTION / Resolution: 2.01 Å

PDB-5sma:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434890
Method: X-RAY DIFFRACTION / Resolution: 2.011 Å

PDB-5smb:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z419995480
Method: X-RAY DIFFRACTION / Resolution: 2.181 Å

PDB-5smc:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2033637875
Method: X-RAY DIFFRACTION / Resolution: 2.19 Å

PDB-5smd:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z274575916
Method: X-RAY DIFFRACTION / Resolution: 1.826 Å

PDB-5sme:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z437584380
Method: X-RAY DIFFRACTION / Resolution: 1.91 Å

PDB-5smf:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z56791867
Method: X-RAY DIFFRACTION / Resolution: 2.011 Å

PDB-5smg:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2092370954
Method: X-RAY DIFFRACTION / Resolution: 1.87 Å

PDB-5smh:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z2856434938
Method: X-RAY DIFFRACTION / Resolution: 2.64 Å

PDB-5smi:
PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with Z71580604
Method: X-RAY DIFFRACTION / Resolution: 2.08 Å

PDB-7fqm:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with FMOPL000619a
Method: X-RAY DIFFRACTION / Resolution: 1.94 Å

PDB-7fqn:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with FMOOA000497a
Method: X-RAY DIFFRACTION / Resolution: 2.04 Å

PDB-7fqo:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with FMOOA000523a
Method: X-RAY DIFFRACTION / Resolution: 1.93 Å

PDB-7fqp:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with FMOOA000505a
Method: X-RAY DIFFRACTION / Resolution: 1.88 Å

PDB-7fqq:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with FMOOA000611a
Method: X-RAY DIFFRACTION / Resolution: 1.88 Å

PDB-7fqr:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with FMOOA000666a
Method: X-RAY DIFFRACTION / Resolution: 1.9 Å

PDB-7fqs:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with FMOOA000555a
Method: X-RAY DIFFRACTION / Resolution: 2.12 Å

PDB-7fqt:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with FMOMB000293a
Method: X-RAY DIFFRACTION / Resolution: 2.54 Å

PDB-7fqu:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with FMSOA000470b
Method: X-RAY DIFFRACTION / Resolution: 1.86 Å

PDB-7fqv:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with XST00000847b
Method: X-RAY DIFFRACTION / Resolution: 2.04 Å

PDB-7fqw:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with FMOCR000171b
Method: X-RAY DIFFRACTION / Resolution: 2.17 Å

PDB-7fqx:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with FMOPL000601a
Method: X-RAY DIFFRACTION / Resolution: 2.46 Å

PDB-7fqy:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with FMOPL000278a
Method: X-RAY DIFFRACTION / Resolution: 2.13 Å

PDB-7fqz:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with FMOMB000203a
Method: X-RAY DIFFRACTION / Resolution: 2.09 Å

PDB-7frf:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with FMOPL000089a
Method: X-RAY DIFFRACTION / Resolution: 2.15 Å

PDB-7frg:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with Z31222641
Method: X-RAY DIFFRACTION / Resolution: 1.84 Å

PDB-7frh:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with Z2856434762
Method: X-RAY DIFFRACTION / Resolution: 1.84 Å

PDB-7fri:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with Z321318226
Method: X-RAY DIFFRACTION / Resolution: 1.86 Å

PDB-7frj:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with Z2856434770
Method: X-RAY DIFFRACTION / Resolution: 1.8 Å

PDB-7frk:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with Z30820160
Method: X-RAY DIFFRACTION / Resolution: 1.8 Å

PDB-7frl:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with Z2856434917
Method: X-RAY DIFFRACTION / Resolution: 1.79 Å

PDB-7frm:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with Z509756472
Method: X-RAY DIFFRACTION / Resolution: 1.91 Å

PDB-7frn:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with Z915492990
Method: X-RAY DIFFRACTION / Resolution: 1.85 Å

PDB-7fro:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with Z744754722
Method: X-RAY DIFFRACTION / Resolution: 1.93 Å

PDB-7frp:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with XST00000245b
Method: X-RAY DIFFRACTION / Resolution: 1.77 Å

PDB-7frq:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with XST00000217b
Method: X-RAY DIFFRACTION / Resolution: 2.01 Å

PDB-7frr:
PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with Z2856434906
Method: X-RAY DIFFRACTION / Resolution: 1.83 Å

PDB-7n7w:
Crystal Structure of SARS-CoV-2 NendoU in complex with CSC000178569
Method: X-RAY DIFFRACTION / Resolution: 2.42 Å

Chemicals

ChemComp-MLI:
MALONATE ION / Malonic acid

ChemComp-NI:
NICKEL (II) ION / Nickel

ChemComp-9KS:
N-(2-hydroxyphenyl)acetamide

ChemComp-HOH:
WATER / Water

ChemComp-AW7:
2-[4-(1~{H}-pyrazol-3-yl)phenoxy]pyrimidine

ChemComp-AWA:
(6~{R})-6-(4-methoxyphenyl)-2-oxidanylidene-5,6-dihydro-1~{H}-pyrimidine-4-carboxylic acid

ChemComp-AWD:
~{N}-(4-fluorophenyl)-4-methyl-piperazine-1-carboxamide

ChemComp-AWG:
~{N}2-(1~{H}-benzimidazol-2-yl)benzene-1,2-diamine

ChemComp-AWM:
2-(4-methylpiperazin-1-yl)-1,3-benzothiazole

ChemComp-AWP:
1-cyclohexyl-3-(2-pyridin-4-ylethyl)urea

ChemComp-AWS:
8-[(dimethylamino)methyl]-4-methyl-7-oxidanyl-chromen-2-one

ChemComp-AWV:
3-(azepan-1-ylmethyl)-1~{H}-indole

ChemComp-AWY:
~{N}-[2-(7-methoxynaphthalen-1-yl)ethyl]ethanamide / antidepressant*YM / Agomelatine

ChemComp-AXG:
1-(phenylmethyl)-4-pyrrol-1-yl-piperidine

ChemComp-AXJ:
[(2~{R})-1-[[(1~{R},5~{S})-6,6-dimethyl-2-bicyclo[3.1.1]hept-2-enyl]methyl]pyrrolidin-2-yl]methanol

ChemComp-AXS:
1-(4-fluorophenyl)-~{N}-[[(2~{R})-oxolan-2-yl]methyl]methanamine

ChemComp-AXV:
1~{H}-benzimidazol-2-ylcyanamide

ChemComp-AY4:
2,4-bis(fluoranyl)-6-(1~{H}-pyrazol-3-yl)phenol

ChemComp-AYJ:
2-[cyclohexyl(methylsulfonyl)amino]ethanamide

ChemComp-AYS:
2-[(4-chlorophenyl)amino]benzamide

ChemComp-AYV:
1-[2-methyl-1,3-bis(oxidanyl)propan-2-yl]-3-phenyl-urea

ChemComp-B0A:
~{N}-cyclohexyl-2-phenoxy-ethanamide

ChemComp-B0G:
(phenylmethyl) 4-oxidanylpiperidine-1-carboxylate

ChemComp-B0J:
4-[[[(4~{S})-2,2-dimethyloxan-4-yl]amino]methyl]phenol

ChemComp-B0M:
1~{H}-indol-6-yl-(4-methylpiperazin-1-yl)methanone

ChemComp-B0V:
2-methoxy-~{N}-(2,4,6-trimethylphenyl)ethanamide

ChemComp-DMS:
DIMETHYL SULFOXIDE / DMSO, precipitant*YM / Dimethyl sulfoxide

ChemComp-B0Y:
5-ethyl-~{N}-[(1-methylpyrazol-4-yl)methyl]thiophene-2-carboxamide

ChemComp-B1A:
~{N}-(4-phenylazanylphenyl)ethanamide

ChemComp-B1J:
[1-(4-chlorophenyl)-1,2,3-triazol-4-yl]methanol

ChemComp-ACT:
ACETATE ION / Acetate

ChemComp-H3D:
N-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)cyclopentyl]acetamide

ChemComp-CL:
Unknown entry / Chloride

ChemComp-GQY:
2-methoxy-4-morpholin-4-yl-aniline

ChemComp-GV1:
~{N},~{N},5,6-tetramethylthieno[2,3-d]pyrimidin-4-amine

ChemComp-GV7:
4-[(5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)amino]phenol

ChemComp-GVY:
4-(5-amino-1,3,4-thiadiazol-2-yl)phenol

ChemComp-GW1:
(4-chloranyl-2-methyl-pyrazol-3-yl)-piperidin-1-yl-methanone

ChemComp-MG:
Unknown entry

ChemComp-K0G:
N-phenyl-N'-pyridin-3-ylurea

ChemComp-EDO:
1,2-ETHANEDIOL / Ethylene glycol

ChemComp-PEG:
DI(HYDROXYETHYL)ETHER / Diethylene glycol

ChemComp-JGD:
N,N-dimethylpyridin-4-amine / 4-Dimethylaminopyridine

ChemComp-LD4:
N-cycloheptylpyrimidin-2-amine

ChemComp-JG4:
2-(thiophen-2-yl)-1H-imidazole

ChemComp-JGP:
(azepan-1-yl)(2H-1,3-benzodioxol-5-yl)methanone

ChemComp-LDV:
3-[(4-methylpiperidin-1-yl)methyl]-1H-indole

ChemComp-LDS:
N-(4-ethoxyphenyl)pyrazine-2-carboxamide

ChemComp-LDJ:
2-methyl-N-{5-[(2S)-oxolan-2-yl]-1,3,4-thiadiazol-2(3H)-ylidene}propanamide

ChemComp-LDD:
(azepan-1-yl)(4-methoxyphenyl)methanone

ChemComp-LD7:
3-ethyl-N-[(4-fluorophenyl)methyl]-1,2,4-oxadiazole-5-carboxamide

ChemComp-LEY:
N-[(4-fluorophenyl)methyl]-2-(propan-2-yl)-1H-imidazole-5-carboxamide

ChemComp-LES:
(3S)-N-(pyrimidin-2-yl)azepan-3-amine

ChemComp-LEJ:
1-(difluoromethyl)-N-[(4-fluorophenyl)methyl]-1H-pyrazole-3-carboxamide

ChemComp-LE7:
N-[(4-fluorophenyl)methyl]-3-propyl-1H-pyrazole-5-carboxamide

ChemComp-LE4:
[2-(cycloheptylamino)pyrimidin-4-yl]methanol

ChemComp-LFP:
5-chloro-N-[(4-fluorophenyl)methyl]-1-methyl-1H-pyrazole-4-carboxamide

ChemComp-LFM:
N-[(4-fluorophenyl)methyl]-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-3-carboxamide

ChemComp-LFJ:
1-[4-(2H-1,3-benzodioxole-5-carbonyl)-2,3,4,5-tetrahydro-1H-1,4-diazepin-1-yl]ethan-1-one

ChemComp-LFG:
N-cycloheptyl-5-cyclopropyl-1,3,4-oxadiazol-2-amine

ChemComp-LF4:
N-[(4-fluorophenyl)methyl]-3-(propan-2-yl)-1H-pyrazole-5-carboxamide

ChemComp-LJ7:
N-[(4-fluorophenyl)methyl]-1-(propan-2-yl)-1H-pyrazole-3-carboxamide

ChemComp-LHS:
N-[(4-fluorophenyl)methyl]-5-(methoxymethyl)-1,2,4-oxadiazole-3-carboxamide

ChemComp-LHM:
N-[(4-fluorophenyl)methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine-3-carboxamide

ChemComp-LH7:
1-[(3S)-1,1-dioxo-1lambda~6~-thiolan-3-yl]-N-[(4-fluorophenyl)methyl]-5-methyl-1H-pyrazole-4-carboxamide

ChemComp-LFY:
1-ethyl-N-[(4-fluorophenyl)methyl]-1H-imidazole-4-carboxamide

ChemComp-LJM:
5-ethyl-N-[(4-fluorophenyl)methyl]-1,3-thiazole-2-carboxamide

ChemComp-LJJ:
N-cycloheptyl-5-methyl-1,3,4-oxadiazol-2-amine

ChemComp-LJD:
N-[(4-chlorophenyl)methyl]-1-methyl-1H-pyrazole-4-carboxamide

ChemComp-JH1:
1-ethyl-N-[(4-fluorophenyl)methyl]-1H-pyrazole-4-carboxamide

ChemComp-LJA:
N-[3-(carbamoylamino)phenyl]acetamide

ChemComp-JGA:
N-ethyl-N'-(5-methyl-1,2-oxazol-3-yl)urea

ChemComp-N5S:
N-(5-methyl-1,2-oxazol-3-yl)-N'-[(3S)-4,4,4-trifluoro-3-hydroxy-3-(5-methylfuran-2-yl)butyl]urea

ChemComp-N5V:
N-ethyl-N'-1,3-thiazol-2-ylurea

ChemComp-N64:
N-(5-methyl-1,2-oxazol-3-yl)-N'-[3-(4-phenylpiperazin-1-yl)propyl]urea

ChemComp-N67:
N-methyl-5-({[(5-methyl-1,2-oxazol-3-yl)carbamoyl]amino}methyl)thiophene-2-sulfonamide

ChemComp-N6D:
N-[3-(methoxymethyl)phenyl]-N'-(5-methyl-1,2-oxazol-3-yl)urea

ChemComp-N6J:
N-{1-[(imidazo[1,2-a]pyridin-2-yl)methyl]-1H-pyrazol-4-yl}-N'-(5-methyl-1,2-oxazol-3-yl)urea

ChemComp-N6V:
N-{1-[2-(diethylamino)ethyl]-1H-indol-5-yl}-N'-(5-methyl-1,2-oxazol-3-yl)urea

ChemComp-N71:
N-(5-methyl-1,2-oxazol-3-yl)-N'-[2-(phenylsulfonyl)ethyl]urea

ChemComp-N74:
N-(1-benzyl-1H-pyrazol-4-yl)-N'-(5-methyl-1,2-oxazol-3-yl)urea

ChemComp-N5D:
N-cyclopropyl-2-(4-{[(5-methyl-1,2-oxazol-3-yl)carbamoyl]amino}-1H-pyrazol-1-yl)acetamide

ChemComp-PLP:
PYRIDOXAL-5'-PHOSPHATE / Pyridoxal phosphate

ChemComp-NSJ:
3-[(thiomorpholin-4-yl)methyl]phenol

ChemComp-NSV:
1-[(2-methyl-1,3-thiazol-5-yl)methyl]piperazine

ChemComp-JHP:
4-chloro-N-cyclopentyl-1-methyl-1H-pyrazole-3-carboxamide

ChemComp-NT7:
N-(2,3-dimethylphenyl)-2-(morpholin-4-yl)acetamide

ChemComp-NTG:
5-(1,4-oxazepan-4-yl)pyridine-2-carbonitrile

ChemComp-NTV:
(2S)-N-(3-chloro-2-methylphenyl)oxolane-2-carboxamide

ChemComp-NU4:
2-methyl-N-(pyridin-4-yl)furan-3-carboxamide

ChemComp-NUA:
N-(1-ethyl-1H-pyrazol-4-yl)cyclobutanecarboxamide

ChemComp-NUG:
1-[(2,5-dihydrothiophen-3-yl)methyl]piperidin-4-ol

ChemComp-NUJ:
trans-3-[(2,6-dimethylpyrimidin-4-yl)(methyl)amino]cyclobutan-1-ol

ChemComp-NUM:
N-[2-(4-hydroxyphenyl)ethyl]pyridine-2-carboxamide

ChemComp-HR5:
~{N}-(cyclobutylmethyl)-1,5-dimethyl-pyrazole-4-carboxamide

ChemComp-JO1:
1-methyl-N-[(thiophen-2-yl)methyl]-1H-pyrazole-5-carboxamide

ChemComp-NUY:
[4-(propan-2-yl)piperazin-1-yl](thiophen-2-yl)methanone

ChemComp-NV7:
1-[(furan-2-yl)methyl]-4-(methylsulfonyl)piperazine

ChemComp-K0V:
methyl 1-(tert-butylcarbamoyl)piperidine-4-carboxylate

ChemComp-LUY:
~{N}-(2-phenylethyl)-1~{H}-benzimidazol-2-amine

ChemComp-NVD:
N-{[4-(dimethylamino)phenyl]methyl}-4H-1,2,4-triazol-4-amine

ChemComp-NVJ:
ethyl benzylcarbamate

ChemComp-NVM:
[(4R)-4-methyl-2,3,4,5-tetrahydro-1H-azepin-1-yl](1,3-thiazol-4-yl)methanone

ChemComp-NVY:
1-ethyl-N-(2-fluorophenyl)piperidin-4-amine

ChemComp-NW4:
3-cyclohexyl-1-(morpholin-4-yl)propan-1-one

ChemComp-J4Q:
4-[(2-methylsulfonylimidazol-1-yl)methyl]-1,3-thiazole

ChemComp-NW7:
3-ethyl-5-methyl-N-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole-4-carboxamide

ChemComp-CD:
Unknown entry

ChemComp-JMM:
[4-(cyclopropanecarbonyl)piperazin-1-yl](furan-2-yl)methanone

ChemComp-NWP:
(2R)-N,2-dimethyl-N-(propan-2-yl)morpholine-4-sulfonamide

ChemComp-NWV:
N-[(1-methyl-1H-pyrazol-4-yl)methyl]furan-2-carboxamide

ChemComp-NWY:
N-[(6-methylpyridin-3-yl)methyl]cyclobutanecarboxamide

ChemComp-K1A:
3-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-5-methyl-1,3,4-thiadiazol-2(3H)-one

ChemComp-NX7:
(2,6-difluorophenyl)(pyrrolidin-1-yl)methanone

ChemComp-NXJ:
(1S)-N,2,2-trimethyl-N-(pyridin-3-yl)cyclopropane-1-carboxamide

ChemComp-NXM:
4-[(3-cyclopropyl-1,2,4-oxadiazol-5-yl)methyl]piperidine

ChemComp-NXS:
[1-(pyrimidin-2-yl)piperidin-4-yl]methanol

ChemComp-NY1:
2-(2-methyl-1,3-thiazol-4-yl)-1-(morpholin-4-yl)ethan-1-one

ChemComp-NY4:
N-{4-[(1S)-1-aminoethyl]phenyl}cyclopropanecarboxamide

ChemComp-GWA:
~{N}-(3-acetamidophenyl)-2-methoxy-ethanamide

ChemComp-NY7:
N-(2-methoxy-5-methylphenyl)glycinamide

ChemComp-K2M:
4-(furan-2-carbonyl)piperazine-1-carboxamide

ChemComp-NYV:
1-(propan-2-yl)-1H-imidazole-4-sulfonamide

ChemComp-NZG:
3-(acetylamino)-4-fluorobenzoic acid

ChemComp-NZD:
4-methyl-N-phenylpiperazine-1-carboxamide

ChemComp-NZ7:
(5R)-N,N-dimethyl-2,9-dioxa-6-azaspiro[4.5]decane-6-carboxamide

ChemComp-NZ4:
N-(3-acetylphenyl)morpholine-4-carboxamide

ChemComp-NZ1:
5-methoxy-1,3-benzothiazol-2-amine

ChemComp-LV4:
1-[2-(trifluoromethyloxy)phenyl]thiourea

ChemComp-JFP:
N-(4-methyl-1,3-thiazol-2-yl)propanamide

ChemComp-NZJ:
1-(3-methylbenzene-1-carbonyl)piperidine-4-carboxamide

ChemComp-O0G:
(2S)-2-[(5-chloro-3-fluoropyridin-2-yl)amino]propan-1-ol

ChemComp-O0J:
N-[4-(2-amino-1,3-thiazol-4-yl)phenyl]acetamide

ChemComp-K2P:
2-(trifluoromethoxy)benzoic acid

ChemComp-O0M:
1-{[4-(propan-2-yl)phenyl]methyl}piperidin-4-ol

ChemComp-O0P:
N-[(3-fluorophenyl)methyl]-N-methylsulfuric diamide

ChemComp-O0S:
N-{4-[(pyrimidin-2-yl)oxy]phenyl}acetamide

ChemComp-O0V:
(2S)-2-[(3-fluoropyridin-2-yl)(methyl)amino]propan-1-ol

ChemComp-O0Y:
3-(diethylamino)phenol

ChemComp-O1A:
N-[4-(4-methylpiperazin-1-yl)phenyl]acetamide

ChemComp-O1D:
3-(benzyloxy)aniline

ChemComp-O1M:
4-(4-fluorophenyl)piperazine-1-carboxamide

ChemComp-O1J:
(benzyloxy)acetic acid

ChemComp-O2A:
N-methyl-1H-indole-7-carboxamide

ChemComp-O2D:
2-cyclohexyl-N-(4H-1,2,4-triazol-4-yl)acetamide

ChemComp-O2J:
(2R)-2-(methoxymethyl)-4-(pyridin-2-yl)morpholine

ChemComp-O2M:
N-[(4-methyl-1,3-thiazol-2-yl)methyl]-1H-pyrazole-5-carboxamide

ChemComp-LVV:
4-[(4-methylphenyl)methyl]-1,4-thiazinane 1,1-dioxide

ChemComp-O2P:
N-(2-hydroxy-4-methylphenyl)-2-methylbenzamide

ChemComp-O3A:
(3S)-N-methyl-N-phenylpyrrolidine-3-carboxamide

ChemComp-O3D:
4-[(furan-2-yl)methyl]-1lambda~6~,4-thiazinane-1,1-dione

ChemComp-O3G:
N-benzyl-1-(4-fluorophenyl)methanamine

ChemComp-O3J:
1-[4-(3-phenylpropyl)piperazin-1-yl]ethan-1-one

ChemComp-O3M:
4-[(3,4-dihydroisoquinolin-2(1H)-yl)methyl]phenol

ChemComp-K0J:
N-ethyl-1H-1,2,3-triazole-4-carboxamide

ChemComp-K3J:
N-ethyl-6-methylpyridazin-3-amine

ChemComp-JHJ:
N-(4-methoxyphenyl)-N'-pyridin-4-ylurea

ChemComp-DSJ:
1-(4-amino-2-hydroxyphenyl)ethan-1-one

ChemComp-UNX:
Unknown entry

ChemComp-SO4:
SULFATE ION / Sulfate

ChemComp-PW7:
4-(trifluoromethyl)pyrimidin-2-amine

ChemComp-PWA:
7-fluoroquinazolin-4(3H)-one

ChemComp-PWD:
5-fluoro-1H-pyrrolo[2,3-b]pyridine

ChemComp-PWG:
3-(difluoromethyl)-8-(trifluoromethyl)[1,2,4]triazolo[4,3-a]pyridine

ChemComp-PWJ:
8-chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridine-7-carbonitrile

ChemComp-PWM:
5-fluoroquinazolin-4(3H)-one

ChemComp-PWP:
6-fluoroquinazolin-4(3H)-one

ChemComp-PWS:
3-methyl-2-(methylsulfanyl)-6-(trifluoromethyl)pyrimidin-4(3H)-one

ChemComp-RU4:
4-(1,2,3-thiadiazol-4-yl)phenyl ethylcarbamate

ChemComp-TRS:
2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL / pH buffer*YM / Tris

ChemComp-HWH:
~{N}-[2-(5-fluoranyl-1~{H}-indol-3-yl)ethyl]ethanamide

ChemComp-RUV:
4-(acetylamino)-N-(4H-1,2,4-triazol-4-yl)benzamide

ChemComp-RUY:
4-(piperidin-1-yl)-1,2,5-oxadiazol-3-amine

ChemComp-RV4:
N-{4-[(morpholin-4-yl)methyl]phenyl}acetamide

ChemComp-M25:
N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE

ChemComp-K3D:
4-acetyl-N-ethylpiperazine-1-carboxamide

ChemComp-ZN:
Unknown entry

ChemComp-RVY:
(5S)-5-methyl-5-[(1-phenyl-1H-1,2,3-triazol-4-yl)methyl]pyrrolidine-2,4-dione

ChemComp-RW7:
(3S)-3,4-dimethyl-3-propyl-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione

ChemComp-RWA:
(5R)-3,3,5-trimethyl-5-[(1-phenyl-1H-1,2,3-triazol-4-yl)methyl]pyrrolidine-2,4-dione

ChemComp-RWD:
(4S,5R)-4-hydroxy-5-methyl-5-[(1-phenyl-1H-1,2,3-triazol-4-yl)methyl]pyrrolidin-2-one

ChemComp-RWG:
(5R)-5-{[1-(4-fluorophenyl)-1H-1,2,3-triazol-4-yl]methyl}-5-methylpyrrolidine-2,4-dione

ChemComp-RWM:
(5S)-5-methyl-5-[(3-phenyl-1,2-oxazol-5-yl)methyl]pyrrolidine-2,4-dione

ChemComp-RY4:
N-[4-(aminomethyl)phenyl]methanesulfonamide

ChemComp-GQJ:
methyl (2~{S},4~{R})-1-(furan-2-ylcarbonyl)-4-oxidanyl-pyrrolidine-2-carboxylate

ChemComp-RYG:
~{N}-[(3~{R})-2-oxidanylideneazepan-3-yl]furan-2-carboxamide

ChemComp-RYM:
4-(benzimidazol-1-ylmethyl)benzenecarbonitrile

ChemComp-RYP:
~{N}-methyl-1-pyridin-4-yl-methanamine

ChemComp-S07:
2-(2,4-dimethylphenoxy)-1-morpholin-4-yl-ethanone

ChemComp-S0P:
~{N}-(4-cyanophenyl)ethanamide

ChemComp-S0S:
(3~{R},4~{R})-1,1-bis(oxidanylidene)-4-(pyridin-3-ylmethylamino)thiolan-3-ol

ChemComp-6SU:
methyl 3-(methylsulfonylamino)benzoate

ChemComp-S0V:
morpholin-4-yl(1,2,3-thiadiazol-4-yl)methanone

ChemComp-S1G:
4-[(phenylmethyl)amino]benzoic acid

ChemComp-GQP:
1-[(4-fluorophenyl)methyl]benzimidazole

ChemComp-S1J:
3-azanyl-4-(pyridin-3-ylmethylamino)benzoic acid

ChemComp-N08:
~{N}-[2-(4-fluorophenyl)ethyl]furan-2-carboxamide

ChemComp-S1M:
methyl 2-[(2~{S})-1-ethanoyl-3-oxidanylidene-piperazin-2-yl]ethanoate

ChemComp-JOV:
3-chloro-N-(1-hydroxy-2-methylpropan-2-yl)benzamide

ChemComp-S1V:
1-ethanoylpiperidine-4-carbonitrile

ChemComp-MH5:
3-[(5-methylthiophen-2-yl)methylamino]benzoic acid

ChemComp-S2J:
methyl 2-[(2~{R})-1-(ethylcarbamoyl)-3-oxidanylidene-piperazin-2-yl]ethanoate

ChemComp-S2S:
4-(methylsulfonylamino)benzamide

ChemComp-S2V:
(1-methylpiperidin-4-yl) 3-fluoranylbenzoate

ChemComp-V3J:
(4,7-dihydro-2H-1lambda~4~,2,3-benzothiadiazol-5-yl)(morpholin-4-yl)methanone

ChemComp-S2Y:
~{N}-[(4-fluorophenyl)methyl]-4-methoxy-aniline

ChemComp-7MU:
4-chloranyl-~{N}-methyl-pyridine-2-carboxamide

ChemComp-S34:
2-cyano-~{N}-(pyridin-4-ylmethyl)ethanamide

ChemComp-RWS:
1-(5-methyl-1,3,4-thiadiazol-2-yl)piperidine

ChemComp-EJQ:
~{N}-(4-fluorophenyl)-2-pyrrolidin-1-yl-ethanamide

ChemComp-RWV:
1-{1-[(2-methyl-1,3-thiazol-4-yl)methyl]piperidin-4-yl}methanamine

ChemComp-JGG:
N-[(4-cyanophenyl)methyl]morpholine-4-carboxamide

ChemComp-RX7:
2-methyl-2-{[(3-methylthiophen-2-yl)methyl]amino}propan-1-ol

ChemComp-RXG:
2-(4-fluorophenoxy)-1-(1H-pyrrol-1-yl)ethan-1-one

ChemComp-K1P:
1-(3-methyl-1,2,4-thiadiazol-5-yl)-1,4-diazepane

ChemComp-RXJ:
4-(4-methylpiperazin-1-yl)benzonitrile

ChemComp-RXS:
3-[(2-methyl-1H-imidazol-1-yl)methyl]benzonitrile

ChemComp-M0J:
N-[(2S)-2-hydroxypropyl]-N'-phenylurea

ChemComp-K0Y:
methyl N-(5-methyl-1,2-oxazole-3-carbonyl)glycinate

ChemComp-S6V:
1-[2-(2-oxidanylidenepyrrolidin-1-yl)ethyl]-3-phenyl-urea

ChemComp-PO4:
PHOSPHATE ION / Phosphate

ChemComp-MPD:
(4S)-2-METHYL-2,4-PENTANEDIOL / precipitant*YM / 2-Methyl-2,4-pentanediol

ChemComp-UQJ:
3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide

ChemComp-T6J:
2-[(methylsulfonyl)methyl]-1H-benzimidazole

ChemComp-UQM:
N-[4-(2-amino-2-oxoethyl)phenyl]acetamide

ChemComp-H04:
1-(2-ethoxyphenyl)piperazine

ChemComp-UQS:
N-[(2-fluorophenyl)methyl]-1H-pyrazol-4-amine

ChemComp-UQV:
[2-(acetylamino)phenyl]acetic acid

ChemComp-7ZC:
1-(5-methoxy-1H-indol-3-yl)-N,N-dimethyl-methanamine

ChemComp-JFS:
[4-(1H-benzimidazol-1-yl)phenyl]methanol

ChemComp-UQY:
1-(methylamino)cyclopentane-1-carboxamide

ChemComp-UR7:
1-(3-fluoro-4-methylphenyl)methanesulfonamide

ChemComp-UR4:
2-methoxy-N-(4-phenyl-1,3-thiazol-2-yl)acetamide

ChemComp-UR1:
3-fluoro-5-methylbenzene-1-sulfonamide

ChemComp-TPP:
THIAMINE DIPHOSPHATE / Thiamine pyrophosphate

ChemComp-T1J:
2-{[(1H-benzimidazol-2-yl)amino]methyl}phenol

ChemComp-WGA:
(3S)-1-(3-fluoropyridin-2-yl)-4,4-dimethylpyrrolidin-3-ol

ChemComp-WGD:
1-{(2S,4S)-4-fluoro-1-[(2-methyl-1,3-thiazol-4-yl)methyl]pyrrolidin-2-yl}methanamine

ChemComp-CIT:
CITRIC ACID / Citric acid

ChemComp-WUG:
1-(2,4-dimethyl-1H-imidazol-5-yl)methanamine

ChemComp-WUJ:
N-[(furan-2-yl)methyl]urea

ChemComp-WUM:
4-[(dimethylamino)methyl]-1,3-thiazol-2-amine

ChemComp-WUS:
(5R)-2-methyl-4,5,6,7-tetrahydro-1H-benzimidazol-5-amine

ChemComp-WUV:
5'-thiothymidine

ChemComp-WUY:
N-(2-aminoethyl)-N'-phenylurea

ChemComp-FAD:
FLAVIN-ADENINE DINUCLEOTIDE / FAD*YM / Flavin adenine dinucleotide

ChemComp-BR:
BROMIDE ION / Bromide

ChemComp-WKY:
N-(3-methylpyridin-4-yl)acetamide

ChemComp-K3A:
N-(5-methyl-1H-pyrazol-3-yl)acetamide

ChemComp-ZQA:
4-ethyl-2-(1H-imidazol-5-yl)-1,3-thiazole

ChemComp-WL7:
4-amino-N-(2-hydroxyethyl)-N-methylbenzene-1-sulfonamide

ChemComp-GWG:
1-methylindazole-3-carboxamide

ChemComp-ZQD:
3-[(2S)-1-(methanesulfonyl)pyrrolidin-2-yl]-5-methyl-1,2-oxazole

ChemComp-WJD:
2-methoxy-N-phenylacetamide

ChemComp-VWG:
N-hydroxyquinoline-2-carboxamide

ChemComp-EJW:
(3-phenyl-1,2-oxazol-5-yl)methylazanium

ChemComp-W3G:
pyridazin-3(2H)-one

ChemComp-WOY:
6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine

ChemComp-ZQG:
3-(1H-imidazol-2-yl)propan-1-amine

ChemComp-ZQJ:
2-methyl-5,6,7,8-tetrahydropyrido[4,3-c]pyridazin-3(2H)-one

ChemComp-ZQM:
N-{2-[(propan-2-yl)sulfanyl]phenyl}urea

ChemComp-2L1:
2-[(4-methyl-1H-imidazol-5-yl)methyl]-1,2,3,4-tetrahydroisoquinoline

ChemComp-U0M:
5-fluoro-1-[(5-methyl-1,3,4-thiadiazol-2-yl)methyl]-1,2,3,6-tetrahydropyridine

ChemComp-I81:
1-[(3-methoxyphenyl)methyl]piperidine-4-carboxamide

ChemComp-I87:
(2S)-N,2-dimethyl-N-(propan-2-yl)morpholine-4-sulfonamide

ChemComp-I8A:
N-(cyclopropylmethyl)-2,2,3,3-tetramethylazetidine-1-carboxamide

ChemComp-I8D:
(4-chlorophenyl)(thiomorpholin-4-yl)methanone

ChemComp-I8G:
2-(4-fluorophenoxy)-1-(pyrrolidin-1-yl)ethan-1-one

ChemComp-I8J:
5-fluoro-1-(1-methylcyclopropane-1-sulfonyl)-1,2,3,6-tetrahydropyridine

ChemComp-I8M:
2-[(morpholin-4-yl)methyl]phenol

ChemComp-LF6:
{(1R,2R)-2-[(Z)-(3-methyl-1,2,4-thiadiazol-5(2H)-ylidene)amino]cyclopentyl}methanol

ChemComp-LFO:
N,1-dimethyl-1H-indole-3-carboxamide

ChemComp-LGR:
2-[acetyl(methyl)amino]benzoic acid

ChemComp-LHR:
N-(1H-indazol-6-yl)acetamide

ChemComp-WNV:
N,N,2,3-tetramethylbenzamide

ChemComp-60P:
3-methylthiophene-2-carboxylic acid

ChemComp-W0G:
(3R)-1-(2-fluorophenyl)-3-(methylamino)pyrrolidin-2-one

ChemComp-LJR:
1-cyclohexyl-N-methylmethanesulfonamide

ChemComp-LJK:
3-methyl-N-(2-methylbutan-2-yl)-1H-pyrazole-5-carboxamide

ChemComp-U1V:
1-(4-fluoro-2-methylphenyl)methanesulfonamide

ChemComp-LJ6:
(2R)-3-(3,5-dimethyl-1,2-oxazol-4-yl)-N,N,2-trimethylpropanamide

ChemComp-LLU:
(2S)-2-(2-fluorophenoxy)propanoic acid

ChemComp-LL0:
2-(difluoromethoxy)benzene-1-sulfonamide

ChemComp-LKU:
3-fluoro-N-(3-hydroxy-4-methylphenyl)benzamide

ChemComp-LKL:
2-[(5-chloro-3-fluoropyridin-2-yl)(methyl)amino]ethan-1-ol

ChemComp-LK6:
N-[(3R)-3-methyl-1,1-dioxo-1lambda~6~-thiolan-3-yl]cyclopropanecarboxamide

ChemComp-WN1:
N-(2-fluorophenyl)-3-methoxybenzamide

ChemComp-JJM:
1-methyl-N-(3-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

ChemComp-UWY:
N-(1-ethyl-1H-pyrazol-4-yl)cyclopentanecarboxamide

ChemComp-ELQ:
[3,4-bis(fluoranyl)phenyl]-(4-methylpiperazin-1-yl)methanone

ChemComp-LO6:
2-(difluoromethoxy)-1-[(2R,6S)-2,6-dimethylmorpholin-4-yl]ethan-1-one

ChemComp-SZE:
4-(3-fluoranylpyridin-2-yl)-1-methyl-piperazin-2-one

ChemComp-LNS:
6-(methylcarbamoyl)pyridine-2-carboxylic acid

ChemComp-UX1:
1-[(2-fluorophenyl)methyl]-N-methylcyclopropane-1-carboxamide

ChemComp-U0V:
2-fluoro-N-[2-(pyridin-4-yl)ethyl]benzamide

ChemComp-LMW:
2-[(4-aminophenyl)(ethyl)amino]ethan-1-ol

ChemComp-LM6:
1-(1-ethyl-1H-pyrazol-5-yl)-N-methylmethanamine

ChemComp-LQP:
2-(difluoromethoxy)-1-[(3aR,6aS)-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]ethan-1-one

ChemComp-LQI:
(1-benzofuran-2-yl)(4-methylpiperidin-1-yl)methanone

ChemComp-WH1:
N-methyl-N-[2-(pyridin-2-yl)ethyl]benzamide

ChemComp-LQ3:
(5S)-5-(difluoromethoxy)pyridin-2(5H)-one

ChemComp-GT4:
~{N}-(4-hydroxyphenyl)-2-methoxy-ethanamide

ChemComp-S5J:
2-[4-(2-methoxyphenyl)piperazin-1-yl]ethanenitrile

ChemComp-LPU:
1-(methanesulfonyl)piperidin-4-ol

ChemComp-WKA:
N-(2,1,3-benzoxadiazol-4-yl)acetamide

ChemComp-VZS:
N-(2-methoxy-5-methylphenyl)-N'-4H-1,2,4-triazol-4-ylurea

ChemComp-LRR:
1-(morpholin-4-yl)-4-phenylbutan-1-one

ChemComp-LRF:
N~2~-(4-cyano-3-methyl-1,2-thiazol-5-yl)-N~2~-methylglycinamide

ChemComp-WKS:
2,4-dimethyl-6-(piperazin-1-yl)pyrimidine

ChemComp-K1S:
N,N-diethyl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine / antagonist*YM / Trapidil

ChemComp-LR9:
3-amino-N-ethyl-N-methylbenzamide

ChemComp-LQV:
(2S)-N-(5-methylpyridin-2-yl)oxolane-2-carboxamide

ChemComp-JKG:
4-({[(thiophen-2-yl)methyl]amino}methyl)phenol

ChemComp-JKA:
(1S,4R,5S,6R)-2-(methylsulfonyl)-2-azabicyclo[3.3.1]nonane-4,6-diol

ChemComp-WUW:
(1R,4R,5R,6S)-2-(methanesulfonyl)-4,6-dimethoxy-2-azabicyclo[3.3.1]nonane

ChemComp-JN1:
(6R)-5,6-dihydro-1H-2,6-methano-1lambda~6~-1lambda~6~,2,5-benzothiadiazocine-1,1,4(3H)-trione

ChemComp-JKJ:
(1R,3R,4S)-3-(methoxymethyl)-2-(methylsulfonyl)-2-azabicyclo[2.2.2]octan-4-ol

ChemComp-JPD:
methyl (1S,3S,4R)-4-hydroxy-3-[(1S)-1-hydroxypropyl]-2-azabicyclo[2.2.2]octane-2-carboxylate

ChemComp-JPV:
(2R,5R,6S)-2,3,4,5,6,7-hexahydro-1H-2,6-methanoazocino[5,4-b]indol-5-ol

ChemComp-JJY:
3,4,6,7-tetrahydroacridine-1,8(2H,5H)-dione

ChemComp-JMV:
(3-chlorophenoxy)acetic acid

ChemComp-JHD:
1-(3,4-dimethoxyphenyl)methanamine

ChemComp-GRY:
~{N}1-(4,6-dimethylpyrimidin-2-yl)benzene-1,4-diamine

ChemComp-WV0:
5-fluoro-1,3-dihydro-2H-indol-2-one

ChemComp-JFJ:
1-(3-chlorophenyl)-N-methylmethanamine

ChemComp-JL4:
5-(2-methyl-1,3-thiazol-4-yl)thiophene-2-carboxylic acid

ChemComp-JLG:
2-(thiophen-2-yl)-1,3-thiazole-4-carboxylic acid

ChemComp-0OI:
N-(2-fluorophenyl)-N'-methylurea

Source
  • homo sapiens (human)
  • zika virus
  • severe acute respiratory syndrome coronavirus 2
  • trypanosoma brucei (eukaryote)
  • porphyromonas gingivalis (bacteria)
KeywordsCELL CYCLE / SGC - Diamond I04-1 fragment screening / PanDDA / XChemExplorer / HYDROLASE / NUDIX domain / TRANSFERASE / macrodomain / NUDT5 / Hydrolase/Transferase / Hydrolase-Transferase complex / TRANSCRIPTION / BROMODOMAIN / BPTF / FALZ / FAC1 / BROMODOMAIN AND PHD FINGER-CONTAINING TRANSCRIPTION FACTOR / FETAL ALZ-50 CLONE 1 PROTEIN / RNA BINDING PROTEIN / CPSF5 / RNA PROCESSING / CLEAVAGE FACTOR / MRNA PROCESSING / NUCLEUS / PHOSPHOPROTEIN / RNA-BINDING / NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 22 / IMMUNE SYSTEM / FIBRINOGEN-RELATED PROTEIN (FREP) / PRO-INFLAMMATORY / DAMAGE-ASSOCIATED MOLECULAR PATTERN (DAMP) / VIRAL PROTEIN / OXIDOREDUCTASE / nsp15 / nendoU / sars-cov-2 / sars / covid / covid19 / OXIDOREDUCTASE/OXIDOREDUCTASE inhibitor / Diamond I04-1 fragment screening / OXIDOREDUCTASE-OXIDOREDUCTASE inhibitor complex / HYDROLASE/HYDROLASE inhibitor / HYDROLASE-HYDROLASE inhibitor complex / peptidase / Porphyromonas gingivalis / Diamond i24 fragment screening / protein tyrosine phosphatase / PTP / protein tyrosine phosphatase 1B / PTP1B / enzyme / allostery / multiconformer

+
About Yorodumi Papers

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242):Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi Papers

Database of articles cited by EMDB/PDB/SASBDB data

  • Database of articles cited by EMDB, PDB, and SASBDB entries
  • Using PubMed data

Related info.:EMDB / PDB / SASBDB / Yorodumi / EMN Papers / Changes in new EM Navigator and Yorodumi

Read more